<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">nature reviews molecular cell biology</title>
				<funder ref="#_vXkcJ5H">
					<orgName type="full">Canadian Institutes for Health Research Foundation</orgName>
				</funder>
				<funder ref="#_czYVctX">
					<orgName type="full">National Institutes of Health</orgName>
					<orgName type="abbreviated">NIH</orgName>
				</funder>
				<funder>
					<orgName type="full">National Institute of General Medical Sciences</orgName>
				</funder>
				<funder ref="#_2UWFS3P #_vt6xVru">
					<orgName type="full">Swiss National Science Foundation</orgName>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Francisco</forename><forename type="middle">S</forename><surname>Mesquita</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Laurenc</forename><surname>Abrami</surname></persName>
							<idno type="ORCID">0000-0002-1774-0481</idno>
						</author>
						<author>
							<persName><forename type="first">Maurine</forename><forename type="middle">E</forename><surname>Linder</surname></persName>
							<idno type="ORCID">0000-0003-2202-9712</idno>
						</author>
						<author>
							<persName><forename type="first">Shernaz</forename><forename type="middle">X</forename><surname>Bamji</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Bryan</forename><forename type="middle">C</forename><surname>Dickinson</surname></persName>
						</author>
						<author>
							<persName><forename type="first">F</forename><surname>Gisou Van Der Goot</surname></persName>
							<idno type="ORCID">0000-0002-8522-274X</idno>
						</author>
						<title level="a" type="main">nature reviews molecular cell biology</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">7D8422EAB97A0B5855B76A2D3CF2E0E6</idno>
					<idno type="DOI">10.1038/s41580-024-00700-8</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.0" ident="GROBID" when="2024-06-12T11:40+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Over the past two decades, protein S-acylation (often referred to as S-palmitoylation) has emerged as an important regulator of vital signalling pathways. S-Acylation is a reversible post-translational modification that involves the attachment of a fatty acid to a protein. Maintenance of the equilibrium between protein S-acylation and deacylation has demonstrated profound effects on various cellular processes, including innate immunity, inflammation, glucose metabolism and fat metabolism, as well as on brain and heart function. This Review provides an overview of current understanding of S-acylation and deacylation enzymes, their spatiotemporal regulation by sophisticated multilayered mechanisms, and their influence on protein function, cellular processes and physiological pathways. Furthermore, we examine how disruptions in protein S-acylation are associated with a broad spectrum of diseases from cancer to autoinflammatory disorders and neurological conditions.</p><p>Sections As transmembrane proteins, ZDHHCs localize to membrane-bound organelles, to which they seem to be targeted via well-established signals (as shown for ZDHHC4 and ZDHHC6) <ref type="bibr" target="#b47">47</ref> . Most ZDHHCs are present in the endoplasmic reticulum (for example, ZDHHC1, ZDHHC4, ZDHHC6 and ZDHHC7) <ref type="bibr" target="#b47">[47]</ref><ref type="bibr" target="#b48">[48]</ref><ref type="bibr" target="#b49">[49]</ref><ref type="bibr" target="#b50">[50]</ref> , including the nuclear envelope (ZDHHC6) <ref type="bibr" target="#b51">51</ref> and Golgi (such as ZDHHC3 and ZDHHC20) <ref type="bibr" target="#b48">48,</ref><ref type="bibr" target="#b52">52</ref> , or are found throughout the entire early secretory pathway (such as ZDHHC2, ZDHHC4, ZDHHC14, ZDHHC19 and ZDHHC21) <ref type="bibr" target="#b53">[53]</ref><ref type="bibr" target="#b54">[54]</ref><ref type="bibr" target="#b55">[55]</ref> . A few ZDHHCs are present both at the plasma membrane and in the endocytic system (ZDHHC2 and ZDHHC5). However, subcellular localization of ZDHHCs is not static. For example, in neurons, blockade of synaptic activity induces the translocation of ZDHHC2 from dendritic shafts to post-synaptic</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Related links</head></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>S-Acyltransferases</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Deacylation enzymes</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Effects of S-acylation on proteins</head><p>Cellular and physiological processes Conclusions 1 Global Health Institute, School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland. <ref type="bibr" target="#b1">2</ref> Department of Molecular Medicine, Cornell University, Ithaca, NY, USA. <ref type="bibr" target="#b2">3</ref> Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, British Columbia, Canada. <ref type="bibr" target="#b3">4</ref> Department of Chemistry, University of Chicago, Chicago, IL, USA. e-mail: gisou.vandergoot@epfl.ch</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Review article</head><p>The thioester linkage between the acyl chain and the cysteine is hydrolytically stable, but can be cleaved by various acyl-thioesterases, referred to in this Review as deacylation enzymes <ref type="bibr" target="#b27">28</ref> (Fig. <ref type="figure">1a</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ZDHHC enzymes</head><p>The human genome encodes 23 zinc-finger and DHHC motif-containing (ZDHHC) enzymes (Fig. <ref type="figure">1b</ref>), whereas the mouse genome encodes 24 zDHHC enzymes <ref type="bibr" target="#b28">29</ref> . These enzymes consist of at least four transmembrane domains <ref type="bibr" target="#b29">30</ref> with the DHHC cysteine-rich domain exposed to the cytoplasm between transmembrane domains 2 and 3 (refs. 30-33) (Fig. <ref type="figure">1c</ref>). The Z in ZDHHC (zDHHC in the mouse) designates two zinc-binding motifs in the cysteine-rich domain <ref type="bibr" target="#b33">34</ref> . Other conserved sequences are aspartate-proline-glycine (DPG), threonine-threonine-x-glutamic acid (TTxE) and a palmitoyltransferase conserved carboxy-terminal (PaCCT) motif <ref type="bibr" target="#b31">32,</ref><ref type="bibr" target="#b32">33,</ref><ref type="bibr" target="#b34">35</ref> . However, ZDHHCs diverge considerably in their amino and C termini, both in length and sequence, and some also harbour other well-defined protein domains, such as ankyrin repeats (ZDHHC13 and ZDHHC17) <ref type="bibr" target="#b35">36</ref> , SH3 domains (ZDHHC6) <ref type="bibr" target="#b37">37</ref> or PDZ-binding motifs (for example, ZDHHC5 and ZDHHC8) <ref type="bibr" target="#b38">38,</ref><ref type="bibr" target="#b39">39</ref> .</p><p>The catalytic process involves two sequential steps. Initially, the DHHC cysteine within the active site undergoes acylation, a process termed auto-acylation, through reaction with an acyl-coenzyme A (acyl-CoA) donor that binds to a CoA-binding surface on the cytosolic face of the ZDHHC <ref type="bibr" target="#b40">40</ref> . Subsequently, this acyl chain is transferred from the DHHC cysteine to a cysteine on the target protein <ref type="bibr" target="#b41">41</ref> . The crystal structures of human ZDHHC20 and zebrafish ZDHHC15 reveal that the four transmembrane domains form a lengthy cavity containing hydrophobic residues that are likely to govern the selection of acyl chain length <ref type="bibr" target="#b30">31</ref> (Fig. <ref type="figure">1d</ref>). Positioned at the entrance of this acyl-binding cavity is the active-site cysteine, presumably to facilitate engagement of the acyl-CoA substrate leading to auto-acylation.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Subcellular localization</head><p>Given the large diversity of S-acylation substrates, perhaps it is not surprising that each individual cell type or tissue expresses many (or even most) ZDHHC family members <ref type="bibr" target="#b42">[42]</ref><ref type="bibr" target="#b43">[43]</ref><ref type="bibr" target="#b44">[44]</ref> , albeit with tissue-specific enrichment of some enzymes (Box 1). Quantitative proteomics has revealed that individual ZDHHC proteins are present in low abundance relative to that of other enzymes that catalyse lipid modifications. Two studies that analysed 9 and 17 different ZDHHCs, respectively, in HeLa cells <ref type="bibr" target="#b45">45,</ref><ref type="bibr" target="#b46">46</ref> reported ZDHHC copy numbers ranging from hundreds for ZDHHC12 to ~5,000 for ZDHHC6 and 15,000-60,000 for ZDHHC5. Even combined, however, the total ZDHHC copy number (43,000-110,000) was still substantially lower than that for N-myristoyltransferase 1 alone (225,000) <ref type="bibr" target="#b45">45</ref> . This observation suggests that ZDHHC enzymes must be very active and therefore require a high level of control. Low enzyme abundance might also favour specificity.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p>For cells to function adequately in a context-dependent manner, the contributions of each protein molecule must be tightly controlled in both time and space. Such fine-tuning is ensured by enzymes that locally and temporally modify the physical and chemical properties of proteins, thereby affecting their function. Some 400 different types of post-translational modifications have been reported <ref type="bibr" target="#b0">[1]</ref><ref type="bibr" target="#b1">[2]</ref><ref type="bibr" target="#b2">[3]</ref> . Among these, lipidation confers hydrophobicity on proteins and, consequently, drives their association with membranes and even with specific membrane subdomains <ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref> . Therefore, lipid modifications are essential for the compartmentalized organization of eukaryotic cells and for enabling these compartments to work together in a coordinated manner. Membrane-bound organelles enable the spatial separation of biochemically incompatible processes. In addition, they offer active, dynamic and spatially restricted membrane surfaces that act as assembly platforms for various cellular processes <ref type="bibr" target="#b6">7</ref> and provide access routes, via vesicular trafficking, to other subcellular locations <ref type="bibr" target="#b6">7,</ref><ref type="bibr" target="#b7">8</ref> .</p><p>Lipid modifications include several forms of fatty acylation: N-myristoylation, N-acylation, O-acylation and S-acylation <ref type="bibr" target="#b4">5,</ref><ref type="bibr" target="#b5">6</ref> . These modifications can be differentiated by the amino acid (glycine, lysine, serine or cysteine) on which the modification occurs, the enzymatic reaction involved, the reversibility of the modification and the type of lipid chain to be attached (saturated or unsaturated, short-chain or long-chain; for example, palmitic (C16) or stearic (C18) acids) <ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref> .</p><p>S-Acylation is reversible by deacylation and, consequently, can act as a dynamic on/off switch, similar to phosphorylation, acetylation and ubiquitylation. As palmitic acid is the most frequently added lipid <ref type="bibr" target="#b8">9</ref> , S-acylation has often been referred to as S-palmitoylation or palmitoylation, even when the specific lipid has not been identified. This post-translational modification is extremely common and could, potentially, affect 10-20% of the human proteome (Box 1). S-Acylation and deacylation cycles consistently influence or control many cellular and physiological processes, including signalling, cell migration and division, inter-organelle and inter-cell communication, energy metabolism, innate immunity and tissue function <ref type="bibr" target="#b3">4,</ref><ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref> . As a consequence, alterations in S-acylation and deacylation dynamics are increasingly found to be associated with a range of human disorders, from metabolic to inflammatory diseases, neurodegeneration and cancer <ref type="bibr" target="#b9">10,</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref> .</p><p>Despite being discovered more than 40 years ago, we stand at the threshold of a new era of growing research interest in S-acylation. This Review describes the structures, functions and regulation of S-acylation and deacylation enzymes. We use specific examples to explore the protein-level implications of S-acylation, the influence of this modification on cellular pathways and its effects on physiological and disease processes. Although we mainly focus on mammals, S-acylation is of crucial importance in all eukaryotic organisms and their pathogens, particularly viruses (Supplementary Box 1). Promising prospects offered by the therapeutic applications of targeting S-acetylation and deacylation enzymes are also discussed.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>S-Acyltransferases</head><p>S-Acylation involves the attachment of medium-chain or long-chain fatty acids to specific cytosolic cysteine residues within proteins <ref type="bibr" target="#b8">9,</ref><ref type="bibr" target="#b22">23</ref> . This modification is mediated by a family of S-acyltransferases that contain a conserved aspartate-histidine-histidine-cysteine (DHHC) cysteine-rich domain first identified in Saccharomyces cerevisiae <ref type="bibr" target="#b23">24</ref> and confirmed by biochemical reconstitution of enzymatic activity <ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref> .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Review article</head><p>densities at the plasma membrane of dendritic spines. Once there, ZDHHC2 modifies post-synaptic density protein 95 (PSD95), which leads to increased recruitment of α-amino-3-hydroxy-5-methyl-4isoxazolepropionic acid (AMPA)-type glutamate receptors <ref type="bibr" target="#b56">56</ref> . Conversely, in response to neuronal activity, ZDHHC5 on synaptic membranes is transported to dendritic shafts where it acylates δ-catenin <ref type="bibr" target="#b57">57</ref> . Together, ZDHHC5 and δ-catenin are then mobilized in recycling endosomes and shuttled back into synapses <ref type="bibr" target="#b57">57</ref> . These studies underscore the integration of spatial regulation of ZDHHC proteins into cellular responses.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Lipid and protein substrate specificity</head><p>ZDHHCs have two levels of specificity: the acyl chain they add and the protein(s) to which it is added. The maximal length and, potentially, also saturation of the acyl chain are determined by the architecture and amino acid composition of the hydrophobic cavity within the tepee structure of ZDHHC enzymes, particularly the interactions with and the size of a pair of residues (Ser29 and Tyr181 for ZDHHC20) present at the end of the lipid-binding cavity <ref type="bibr" target="#b30">31,</ref><ref type="bibr" target="#b31">32,</ref><ref type="bibr" target="#b58">58,</ref><ref type="bibr" target="#b59">59</ref> (Fig. <ref type="figure">1d</ref>). Except for viral glycoproteins (Supplementary Box 1), the identity of the acyl chain attached to a protein by ZDHHCs has rarely been determined <ref type="bibr" target="#b60">60,</ref><ref type="bibr" target="#b61">61</ref> .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Box 1</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Protein S-acylation bioinformatic tools</head><p>Several online databases facilitate the study of protein S-acylation. SwissPalm provides a catalogue of S-acylated proteins and some analysis tools; RNA sequencing (RNA-seq) data on genes that regulate S-acylation are provided for the brain by BrainPalmSeq and for various human single cells and bulk RNA-seq by CellPalmSeq.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>SwissPalm</head><p>This centralized multi-species database catalogues all reported S-acylation substrates and is composed of curated proteome data sets and experimental validation data from the literature. SwissPalm provides a tool to search for any given protein and returns a summary of the number of times this protein has been identified in an acyl-proteome data set or validated experimentally. Currently, close to 25% of the human proteome appears at least once in reported acyl-proteomes. Mass spectrometry has a substantial statistical false discovery rate, however, and hydroxylamine-dependent capture of proteins in addition generates a level of background detection (Box 2). Validation of S-acylation by other methods (Box 2) and determination of the biological relevance of the acylation have so far only been performed for a limited number of proteins. However, we can safely conclude that S-acylation is a very common post-translational modification, the precise extent of which remains to be determined. Moreover, proteomics studies do not directly confirm the S-acylation of all hits. In the search output for each protein, SwissPalm provides S-acylation site prediction data using PalmPred and CSS-Palm tools <ref type="bibr" target="#b264">264,</ref><ref type="bibr" target="#b265">265</ref> . Additional tools facilitate the rapid comparison of large protein lists with the SwissPalm database and offer many modular layers of filtering (including by species and by the curated SwissPalm evidence for a protein being an S-acylation substrate). Knowledge of whether a protein or group of proteins are substrates for S-acylation is extremely useful when trying to understand how S-acylation might alter any given biological pathway. The SwissPalm proteome comparison tool enables rapid identification of S-acylation substates included within large data sets and protein lists, which can then be assessed to determine the percentage of S-acylation substrates within the list. Identified substrates can be analysed using other bioinformatic ontology-based tools, such as STRING and Gene Ontology (GO).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>BrainPalmSeq</head><p>This curated online database of RNA-seq data covers the genes that regulate S-acylation in the brain, including the zinc-finger and aspartate-histidine-histidine-cysteine (DHHC) motif-containing (ZDHHC) enzymes, the best-characterized deacylation enzymes and known ZDHHC accessory proteins. The tool was created by collating expression data from numerous previously published single-cell and bulk RNA-seq studies, reanalysing the data using the same analysis pipeline for all data sets, and summarizing the data in standardized, easy-to-use, interactive heatmaps. The relative expression of each S-acylation-associated gene can either be summarized across all cell types or brain regions in a selection of data sets or searched within individual data sets according to brain region or cell type. Drop-down menus can be used to highlight and compare the expression of genes that regulate S-acylation in selected cell types. This tool can be used to identify which specific ZDHHC and deacylation enzymes are likely to have the most influence over protein S-acylation in different cellular contexts in the brain, which is composed of hundreds of unique and highly divergent cell types. BrainPalmSeq can also be used to investigate how the expression patterns of disease-linked genes that regulate S-acylation might relate to disease aetiology and to predict enzyme-substrate interactions for S-acylation substates in specific cell types.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CellPalmSeq</head><p>This database parallels BrainPalmSeq but covers human single-cell and bulk RNA-seq data derived from hundreds of cancer cell lines that are a mainstay of biological and cancer research as well as commonly used non-human cell lines. The relative expression patterns of genes that regulate S-acylation can be quickly compared using interactive heatmaps organized by dataset. Bar charts also enable the comparison of the expression of each individual gene across many tissues and cell types in the human body, or in cancer cell lines with a similar origin. This tool is particularly useful for researchers and cell biologists who use immortalized cell lines to investigate S-acylation-regulated processes, including in vaccine development, drug toxicity research, protein production and studies of gene function. Given the well-established role of tumour-promoting protein S-acylation in cancer progression, this tool can enable cancer researchers to determine which S-acylation and deacylation enzymes are enriched in cancer cell lines and how these enzymes might be targeted for cancer therapies. A target protein of interest is acylated at the thiol of a target cysteine residue by zinc-finger and aspartate-histidine-histidine-cysteine (DHHC) motif-containing (ZDHHC) enzymes, which use acyl-coenzyme A (acyl-CoA) molecules (such as palmitoyl-CoA, shown) as an acyl donor. The thioestertethered lipid modification can be removed through hydrolysis mediated by deacylation enzymes such as acyl-protein thioesterases (APTs). ZDHHC and APT inhibitors, as well as imaging probes, enable the perturbation and study of this dynamic regulatory process. b, Phylogenetic tree of ZDHHC S-acyltransferases. The 23 human ZDHHCs are categorized into subfamilies on the basis of their full-length amino acid sequences. c, Core membrane topology and conserved sequence motifs. ZDHHC proteins contain at least four transmembrane domains. The conserved DHHC cysteine-rich domain (green) includes the canonical DHHC motif (magenta) situated on the cytoplasmic face of the lipid bilayer. Additional conserved features include an aspartic acid-proline-glycine (DPG) motif of unknown function that lies adjacent to transmembrane domain 2 on the cytoplasmic face of the membrane (yellow); a threonine-threonine-xglutamic acid (TTxE) motif that interacts with the catalytic DHHC and is required for robust enzymatic activity <ref type="bibr" target="#b30">31</ref> (red); and a palmitoyltransferase conserved carboxy-terminal (PaCCT) motif, part of an amphipathic helix that interacts with transmembrane domains 3 and 4 and contributes to stabilization of the C-terminal domain <ref type="bibr" target="#b30">31</ref> (blue). In a subset of ZDHHCs, cysteine residues within the PaCCT motif are S-acylated <ref type="bibr" target="#b70">70,</ref><ref type="bibr" target="#b71">71,</ref><ref type="bibr" target="#b77">77</ref> . d, Structures of ZDHHC20 (Protein Database (PDB) entry [PDB:6BML]) <ref type="bibr" target="#b30">31</ref> and the ZDHHC9-golgin subfamily A (GOLGA) member 7 (GCP16) heterodimer [PDB:8HF3] <ref type="bibr" target="#b73">73</ref> . The four transmembrane domain helices in ZDHHC20 and ZDHHC9 (blue) form a tepee-like cavity into which the acyl chain of the acyl-CoA co-substrate is inserted. Cytoplasmic regions flanking the green DHHC cysteine-rich domain are shown in white. Two zinc ions (brown spheres) are positioned between β-hairpins, each coordinated by three cysteines and a histidine. The zinc ions do not coordinate the active-site cysteine in the DHHC motif and are not involved in catalysis but, rather, serve a structural role <ref type="bibr" target="#b30">31</ref> . In the ZDHHC9-GCP16 complex <ref type="bibr" target="#b73">73</ref> , GCP16 (red) lacks a transmembrane domain but has two α-helices that insert into the membrane and interact with transmembrane domains 2 and 3. The position of these helices is analogous to that of the hydrophobic loop in ZDHHC20 (red-loop), which stabilizes the structure to fully support enzyme activity <ref type="bibr" target="#b30">31</ref> . The hydrophobic loop of GCP16 probably fulfils a similar function and might partly account for the requirement of ZDHHC9 for an accessory protein. Three additional interfaces drive the main interactions of GCP16 and ZDHHC9: two involve the zinc-finger motifs and the third contacts a polyproline helix near the end of the cytoplasmic domain. Together, these interactions stabilize the structure of ZDHHC9 and promote its catalytic activity. CMA, cyano-myracrylamide.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Review article</head><formula xml:id="formula_0">Inhibitors • 2-Bromopalmitate (non-speci ic) • СМА Inhibitors • 2-Bromopalmitate (non-speci ic) • Palmostatin B (pan-active) • ML348 (APT1) • ML349 (APT2) • ABD957 (ABHD17)</formula></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Review article</head><p>Therefore, although some ZDHHC enzymes might have the ability to add various lengths of acyl chains <ref type="bibr" target="#b22">23</ref> , it is unclear whether they actually do so, whether acyl chain length is controlled and what the consequences of varying the acyl chain length might be.</p><p>Defining substrate selectivity rules for ZDHHC proteins is an ongoing challenge. Some enzymes (such as ZDHHC17) seem to be very selective <ref type="bibr" target="#b62">62</ref> , whereas others, such as ZDHHC3 and ZDHHC7, are fairly promiscuous <ref type="bibr" target="#b39">39,</ref><ref type="bibr" target="#b48">48,</ref><ref type="bibr" target="#b63">63,</ref><ref type="bibr" target="#b64">64</ref> . Subcellular protein distribution provides a first level of specificity because it dictates where enzymes and substrates can interact. ZDHHC substrate specificity could arise also from the divergent N and C termini. For example, ZDHHC17 and ZDHHC13 harbour ankyrin repeat domains that bind to a short linear sequence motif in their respective substrates. The ankyrin repeat of ZDHHC17 binds to a short peptide in SNAP25 (synaptosomal-associated protein 25, a target (t) soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE)) and in huntingtin, a key ZDHHC17 target <ref type="bibr" target="#b62">62,</ref><ref type="bibr" target="#b65">65</ref> . However, ankyrin-independent binding has also been reported <ref type="bibr" target="#b35">36,</ref><ref type="bibr" target="#b66">66</ref> . Other ZDHHCs, such as ZDHHC5, ZDHHC8 and ZDHHC14, bear PDZ-binding motif domains. For example, a PDZ-binding motif in ZDHHC5 facilitates its binding to the neuronal scaffold protein PSD95 (refs. 39,67). Substrate recognition might also occur within the membrane: as an example, ZDHHC6 recognizes both type I and type II transmembrane domain proteins as substrates, and S-acylation by ZDHHC6 seems to require only a juxtamembranous cysteine residue <ref type="bibr" target="#b68">68</ref> , a feature that is consistent across all validated ZDHHC6 substrates <ref type="bibr" target="#b37">37,</ref><ref type="bibr" target="#b42">42,</ref><ref type="bibr" target="#b50">50,</ref><ref type="bibr" target="#b69">69</ref> . Emerging evidence suggests that even low-affinity interactions between ZDHHC proteins and target peptide sequences can display striking selectivity. S-Acylation of the G protein α-subunit (Gα o ) is dependent only on a short N-myristoylated sequence. When the N-terminal peptide of Gα o was appended to green fluorescent protein, minor changes in the amino acid sequence could change it from a substrate for ZDHHC3 localized at the Golgi to a substrate for ZDHHC11 localized at the plasma membrane <ref type="bibr" target="#b55">55</ref> .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ZDHHC regulation</head><p>The mechanisms that regulate the activity of ZDHHC enzymes are only now starting to be understood. These mechanisms include transcriptional regulation, post-translational modification and interaction with accessory proteins. Of note, cells can also regulate the abundance of fatty acids, which influences the ability of ZDHHCs to modify their substrates.</p><p>Accessory proteins. Most ZDHHCs function as homomeric enzymes. However, a subset of ZDHHCs can form heterodimers with an accessory protein <ref type="bibr" target="#b70">70</ref> . The founding acyltransferase, yeast Erf2, requires association with accessory protein Erf4 for enzyme activity and protein stability <ref type="bibr" target="#b24">25</ref> . The mammalian counterpart of Erf4, GOLGA7 (also known as GCP16), associates with ZDHHC9, ZDHHC14 and ZDHHC18 (refs. 71,72). GOLGA proteins are present in the Golgi and thought to be involved in the formation and function of the Golgi apparatus. Both yeast Erf4 and GOLGA7 stabilize the structure of the heterodimers, and thereby enable the ZDHHC protein to adopt a conformation that is capable of efficient catalysis. Published cryo-electron micrography structures of ZDHHC9-GOLGA7 and yeast Erf2-Erf4 heterodimers reveal a conserved binding mode mediated by interactions at four main interfaces <ref type="bibr" target="#b73">73</ref> (Fig. <ref type="figure">1e</ref>). Neither GOLGA7 nor Erf4 seems to play a direct role in the catalytic mechanism or in substrate recognition. ZDHHC5 also associates with GOLGA7 and the related accessory protein GOLGA7B (refs. 74,75), which suggests that heterodimer formation extends to other ZDHHC9 subfamily members (Fig. <ref type="figure">1b</ref>). However, GOLGA7 and GOLGA7B are probably not necessary for ZDHHC5 function, given that binding of ZDHHC5 to the sodium pump and to GOLGA7B occurs at overlapping sites in its C-terminal domain <ref type="bibr" target="#b76">76</ref> .</p><p>Post-translational modifications. Phosphorylation, ubiquitylation and S-acylation are prominent post-translational modifications of ZDHHCs that have consequences for their enzyme activity, proteinprotein interactions, localization and protein stability <ref type="bibr" target="#b77">77,</ref><ref type="bibr" target="#b78">78</ref> . The mechanisms that underlie the installation and removal of post-translational modifications in ZDHHCs, and the functional sequelae of these events, are only beginning to be uncovered <ref type="bibr" target="#b37">37,</ref><ref type="bibr" target="#b79">79,</ref><ref type="bibr" target="#b80">80</ref> .</p><p>Increased synaptic activity leads to the sequential phosphorylation of ZDHHC5 (mediated by cyclin-dependent kinase 5 and polo-like kinase 2, respectively) on two serine residues within its polo-box domain <ref type="bibr" target="#b80">80</ref> . Dual phosphorylation leads to ZDHHC5 degradation, presumably by enabling its ubiquitylation <ref type="bibr" target="#b80">80</ref> . By contrast, phosphorylation of ZDHHC13 leads to increased binding to and S-acylation of its substrate, melanocortin-1-receptor (MC1R). S-Acylation of MC1R results in increased signalling to its downstream effectors, a process that prevents melanoma carcinogenesis <ref type="bibr" target="#b79">79,</ref><ref type="bibr" target="#b81">81</ref> .</p><p>Many ZDHHC enzymes also undergo regulatory S-acylation at locations outside the active-site cysteine, which can be monitored using various methods (Box 2). The mechanism of regulatory S-acylation was initially proposed to be intramolecular transfer of the acyl chain from the active site to distal cysteines <ref type="bibr" target="#b82">82</ref> but we now appreciate that ZDHHC proteins participate in S-acyltransferase cascades in a manner analogous to those involving protein kinases. For example, ZDHHC6 is S-acylated by ZDHHC16 at three cysteine residues within its C-terminal cytoplasmic domain. Reversible S-acylation at these sites is finely tuned and results in site-specific regulation of ZDHHC6 enzyme activity and stability <ref type="bibr" target="#b37">37</ref> . ZDHHC5 is S-acylated within its C-terminal PaCCT motif by ZDHHC20 at cysteines that mediate the interaction of ZDHHC5 with GOLGA7B (ref. 75) and facilitate substrate recruitment <ref type="bibr" target="#b76">76</ref> . Conservation of S-acylation at cysteines within or adjacent to the PaCCT motif in other ZDHHC proteins is supported by mass spectrometry data <ref type="bibr" target="#b83">83</ref> , which suggests that additional S-acyltransferase cascades remain to be identified.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Transcriptional regulation.</head><p>Studies of S-acylation of the spike protein of SARS-CoV-2 virus revealed that it is S-acylated by ZDHHC20 (refs. 52,84) and that ZDHHCs might undergo transcriptional regulation <ref type="bibr" target="#b85">85</ref> . In response to infection with SARS-CoV-2, extended transcripts of ZDHHC20 are generated from a transcriptional start site upstream of the canonical site, which results in an enzyme with an N-terminal extension. This long isoform is retained in the endoplasmic reticulum (as opposed to the Golgi localization of canonical ZDHHC20). Retention leads to greatly enhanced S-acylation of the SARS-CoV-2 spike protein following its synthesis in the endoplasmic reticulum and viral budding in the endoplasmic reticulum-Golgi intermediate compartment. Viruses carrying S-acylated spike proteins have increased fusogenic capacity during infection.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Inhibitors</head><p>Few small molecule inhibitors of ZDHHC enzymes are known <ref type="bibr" target="#b86">86</ref> (Table <ref type="table">1</ref>). For decades, the gold-standard ZDHHC inhibitor was 2-bromopalmitate, which covalently binds to the ZDHHC active-site cysteine and effectively inhibits enzymatic activity <ref type="bibr" target="#b87">87</ref> . However, this agent has numerous off-target effects <ref type="bibr" target="#b88">88</ref> and also interferes with deacylation Review article enzymes <ref type="bibr" target="#b48">48,</ref><ref type="bibr" target="#b89">89</ref> , which introduces complexity by disrupting the delicate equilibrium between lipid installation and removal in unpredictable ways. Development of cyano-myracrylamide (CMA), a covalent ZDHHC inhibitor with improved selectivity <ref type="bibr" target="#b90">90,</ref><ref type="bibr" target="#b91">91</ref> , facilitated investigation of the dynamic lipidation of ERK1 and ERK2 (ref. 92). However, the search for new potent and highly selective ZDHHC inhibitors has proven extremely challenging. Screens yielded either agents with no notable activity <ref type="bibr" target="#b93">93</ref> or moderately potent, non-covalent inhibitors <ref type="bibr" target="#b94">94</ref> . An orthogonal ligand-enzyme genetic strategy that relies on using a mutation to make a small cavity in the structure of the enzyme that can be filled by a ligand with a corresponding pump (known as a 'bumped' lipid probe) and its corresponding mutant ZDHHC enzyme pair enables targeted substrate examination and inhibition of ZDHHCs. This technique provides a valuable approach to map ZDHHC substrate and function connectivity <ref type="bibr" target="#b58">58,</ref><ref type="bibr" target="#b59">59</ref> at locations outside the active-site cysteine.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Deacylation enzymes</head><p>S-Acylation is reversed by deacylation enzymes of the metabolic serine hydrolase superfamily. These enzymes use a conserved catalytic serine for nucleophilic attack on a target electrophile, which in protein S-acylation is the thioester carbonyl group. The resultant ester intermediate is hydrolysed by water, thereby regenerating the enzyme in a simple catalytic mechanism.</p><p>The current known deacylation enzymes include acyl-protein thioesterase 1 (APT1) and APT2 (also known as LYPLA1 and LYPLA2, respectively); palmitoyl-protein thioesterase 1 (PPT1); and α/β-hydrolase</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Box 2</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Techniques for studying protein S-acylation</head><p>Various methods have been developed to study S-acylation, each having its advantages and each providing somewhat different information (illustrated in Supplementary Fig. <ref type="figure">1</ref>). To determine whether a protein can be S-acylated, on which site and with what stoichiometry, we recommend using multiple methods. Acyl-biotin exchange (ABE), acyl resin-assisted capture (acyl-RAC) and metabolic labelling reveal whether a protein can be acylated. Use of hydroxylamine controls ensures that the detected signals are due to thioester linkages to cysteines. Cysteine mutagenesis can be used for confirmation and site identification. Mass spectrometry can determine which fatty acid has been attached to which cysteine <ref type="bibr" target="#b61">61,</ref><ref type="bibr" target="#b266">266,</ref><ref type="bibr" target="#b267">267</ref> . Often, however, such precise identification is not feasible owing to limited sample amounts, the difficulty of isolating lipidated proteins (particularly transmembrane proteins) and the inherent lability of the thioester modification. Identification of the involved zinc-finger and aspartate-histidine-histidinecysteine (DHHC) motif-containing (ZDHHC) enzyme strengthens conclusions about the S-acylation status of a protein. Finally, stochiometric information can be obtained by acyl-polyethylene glycol exchange, which involves the covalent attachment of one PEG molecule (PEGylation) to each acyl-modified cysteine residue.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ABE and acyl-RAC</head><p>These methods involve protecting all unmodified cysteines in the proteome, followed by selective exposure of the thioester-modified cysteines to the intervention and enrichment based on the presence of those cysteines. Cysteine modification via S-acylation is indicated by the unique chemical reactivity of the thioester to hydroxylamine-mediated hydrolysis. ABE and acyl-RAC offer the advantage of enabling downstream proteomic analysis of the entire population of S-acylated proteins in the sample analysed, which provides a snapshot of the acylated proteome. The disadvantages of these methods are that the identity of the specific thioester modification (that is, S-acylation versus other thioester modifications) is not determined, nor is stoichiometry, as it is an enrichment-based approach.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cysteine PEGylation</head><p>Cysteine PEGylation is a derivative of the ABE and acyl-RAC assays, except that rather than tagging the thioester-modified proteome sites with an affinity handle, the sites are mass-tagged with a long PEG molecule. Western blot analysis can then be used to elucidate the approximate stoichiometry of the modified sites by comparing the relative signals of the unmodified and modified band(s) in the gel. Disadvantages are the same as those for ABE and acyl-RAC assays, most notably that this method does not determine the type of thioester modification.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Metabolic labelling</head><p>Incorporation of either radiolabelled or clickable lipids, followed by analysis using either gel electophoresis (for radiolabelling) or click chemistry, followed by enrichment (for clickable lipids) provides a crucial set of orthogonal information. These methods provide some information about lipid identity, determined by which lipids are incorporated or not, and they distinguish fatty acids linked to proteins from other types of cysteine thioesters, such as ubiquitin. Some caution must be taken with clickable lipids, which are synthetic surrogates of the natural lipid substrate. Thus, although such studies are qualitatively useful for determining the preferred acyl chain length, they are not conclusive. A unique advantage of metabolic labelling methods is that they can provide information about dynamic changes in protein S-acylation over time (by using different times of labelling with radiolabelled or clickable lipids), as well as the turnover rate of the acyl chain (in pulse-chase experiments). Therefore, metabolic labelling methods provide invaluable information on the dynamics of acylation-deacylation cycles <ref type="bibr" target="#b27">28,</ref><ref type="bibr" target="#b266">266</ref> . Advantages include the amenability of metabolic labelling with clickable lipids to downstream proteomic analysis. Disadvantages include the fact that this method is not inherently selective for thioester-based proteome modifications. However, the addition of a control to distinguish which modifications are sensitive to hydroxylamine deprotection can be employed to indicate S-acylation sites. Also, these methods inform only about proteins that were modified during the labelling period, and do not provide a snapshot of the acylated proteome (unlike ABE and acyl-RAC).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Review article</head><p>domain-containing protein 10 (ABHD10), ABHD17A, ABHD17B and ABHD17C (refs. 4,95,96). Structures have been solved for PPT1 (ref. 97), APT1 and APT2 (refs. 98,99), and ABHD10 (ref. 100). The active sites of these enzymes contain a Ser, His and Asp catalytic triad with confirmed deacylating activity for various substrates in vitro (APT1, APT2, PPT1 and ABDH10) and/or sensitivity to deacylation inhibitors and activity-based probes (ABHD6, ABHD12, ABHD13, ABHD16A, ABHD17A, ABHD17B and ABHD17C) <ref type="bibr" target="#b27">28,</ref><ref type="bibr" target="#b96">96,</ref><ref type="bibr" target="#b98">98,</ref><ref type="bibr" target="#b101">[101]</ref><ref type="bibr" target="#b102">[102]</ref><ref type="bibr" target="#b103">[103]</ref> . Lysophospholipase activity has also been reported for APT1, APT2, ABHD6, ABHD12 and ABHD16A (refs. 104-106).</p><p>A comprehensive view of deacylation is now surfacing. To access their targets, acyl-thioesterases must first bind to cell membranes. Membrane binding is an important regulatory event that does not involve recognized lipid-interacting motifs (as shown for APT1 and APT2) but, instead, relies on electrostatic interactions with positively charged residues in cooperation with the membrane insertion of a hydrophobic loop, the so-called β-tongue <ref type="bibr" target="#b48">48</ref> . Subsequently, stable membrane association is mediated by S-acylation of APTs and ABHD17A, ABHD17B and ABHD17C (ref. 107), which are otherwise soluble proteins. Intriguingly, structural predictions suggest that ABHD16A has four transmembrane regions <ref type="bibr" target="#b108">108</ref> . By contrast, once APT1 and APT2 achieve stable association with a membrane, these deacylation enzymes must extract the acyl chain attached to their substrate from the membrane and position it in a hydrophobic pocket, which enables correct positioning of the thioester bond at the active site <ref type="bibr" target="#b48">48</ref> .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Localization</head><p>Thioesterases that have regulatory roles in S-acylation and deacylation cycles must necessarily reside in the cytosol, as the location of ZDHHC enzyme activity (Fig. <ref type="figure">1c</ref>). Interestingly, in terms of copy numbers per cell, the thioesterases are each 10-100 times more abundant than the ZDHHC enzymes <ref type="bibr" target="#b45">45,</ref><ref type="bibr" target="#b46">46</ref> , probably to ensure that the changes induced by S-acylation can be efficiently terminated when necessary. Bone disorders: osteoporosis, bone malformations, dysregulation of osteogenic differentiation</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Table 1 | Associations between protein S-acylating or deacylation enzymes and disease or physiological processes</head><formula xml:id="formula_1">ZDHHC1 b , ZDHHC2 b , ZDHHC12 b , ZDHHC13 a-d , ZDHHC16 a,b,d APT1 a,b,d Cystic fibrosis ZDHHC7 a,b,d Not studied Immune response dysregulation ZDHHC1 a,b,d , ZDHHC2 a,d , ZDHHC3 a,b,d , ZDHHC4 a,d , ZDHHC5 a,d , ZDHHC6 a,b,d , ZDHHC7 a,b,d , ZDHHC9 a,d , ZDHHC11 a,b,d , ZDHHC12 a,b,d , ZDHHC13 a,d , ZDHHC14 c,d , ZDHHC15 a,d , ZDHHC16 a,b,d , ZDHHC17 a,b , ZDHHC18 a,b,d , ZDHHC20 a,d , ZDHHC21 a-d APT1 a,d , APT2 a,d Cardiovascular diseases ZDHHC5 a-d , ZDHHC6 a,c,d , ZDHHC7 a,b,d , ZDHHC8 c , ZDHHC9 a,b,d , ZDHHC14 a-d , ZDHHC16 a,b,d , ZDHHC17 a-d , ZDHHC21 a,b,d APT1 a,d</formula><p>Cancers: skin, breast, colon, ovarian, prostate, lung, liver, pancreas, kidney, bladder, bone, glaucoma, lymphoma, leukaemia, glioblastoma</p><formula xml:id="formula_2">ZDHHC1 a-c , ZDHHC2 a-d , ZDHHC3 a,b,d , ZDHHC4 b,d , ZDHHC5, ZDHHC6 a,d , ZDHHC7 b , ZDHHC8 b , ZDHHC9 a,b,d , ZDHHC11 b , ZDHHC12 b , ZDHHC13 a-d , ZDHHC14 b,c , ZDHHC15 b , ZDHHC16 d , ZDHHC17 a,b,d , ZDHHC18 b , ZDHHC19 b,d , ZDHHC20 a,b , ZDHHC21 b,d , ZDHHC22 b,d , ZDHHC23 b APT1 a,b,d , APT2 a,d , APT1L a,d , PPT1 d , ABHD17s a,b,d Metabolic diseases: obesity, diabetes, liver diseases ZDHHC1 b , ZDHHC3 a,b,d , ZDHHC4 d , ZDHHC5 a,d , ZDHHC6 c,d , ZDHHC7 a,b,d , ZDHHC8 b , ZDHHC12 b , ZDHHC13 b,d , ZDHHC14 b , ZDHHC17 b,d APT1 a,b,d , APT2 a,b,d</formula><p>Mental disorders: schizophrenia, bipolar disorder, memory and learning deficits, behavioural deficits, hyperactivity, visual and cognitive deficits, epilepsy, autism, depression, psychosis Illustrative examples for which the activity a , expression level b or mutations c of zinc-finger and aspartate-histidine-histidine-cysteine (DHHC) motif-containing (ZDHHC) and acyl-protein thioesterase (APT) enzymes or their specific S-acylated substrates d have been linked with disorders and physiological processes in various models. References are indicated in Supplementary Table <ref type="table">1</ref> and provided in the Supplementary References. ABHD, α/β-hydrolase domain-containing protein; CLN1, neuronal ceroid lipofuscinosis type 1; PPT1, palmitoyl-protein thioesterase 1.</p><formula xml:id="formula_3">ZDHHC2 a-d , ZDHHC3 b,d , ZDHHC5 a-d , ZDHHC7 a,b,d , ZDHHC8 b,d , ZDHHC9 a-d , ZDHHC12 c , ZDHHC13 a-d , ZDHHC14 b , ZDHHC15 a-d , ZDHHC17 a-d , ZDHHC18 b , ZDHHC19 d , ZDHHC20 c , ZDHHC21 c</formula></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Review article</head><p>Cytosolic localization has been shown for APT2, a minor but functionally important pool of APT1, ABHD17A, ABHD17B and ABHD17C, and probably also other deacylation enzymes yet to be identified <ref type="bibr" target="#b48">48,</ref><ref type="bibr" target="#b101">101,</ref><ref type="bibr" target="#b103">103,</ref><ref type="bibr" target="#b109">109</ref> . Importantly, deacylation enzymes are found in other subcellular locations; however, such enzymes cannot contribute to regulation of S-acylation and deacylation cycles.</p><p>Only one non-regulatory deacylation enzyme is known to be involved in the lysosomal degradation of S-acylated proteins, namely PPT1. Mutations in PPT1 are associated with the devastating neurodegenerative disease neuronal ceroid lipofuscinosis type 1 (CLN1) <ref type="bibr" target="#b110">110</ref> (Table <ref type="table">1</ref>). PPT1 is consistently abundant (500,000-1,000,000 copies per cell <ref type="bibr" target="#b3">4,</ref><ref type="bibr" target="#b45">45,</ref><ref type="bibr" target="#b46">46</ref> ) inside late endosomes and/or lysosomes, and this localization is driven by its N-terminal signal sequence and by mannose-6-phosphate modification in the Golgi, even though a cytosolic presence of PPT1 has also been reported <ref type="bibr" target="#b3">4</ref> . APT1 and ABHD10 primarily localize to mitochondria, as revealed by activity-based imaging and subcellular fractionation <ref type="bibr" target="#b100">100,</ref><ref type="bibr" target="#b109">109</ref> . The role of APT1 in mitochondria remains to be established, although a proteomic study in mice with liver-specific double-knockout of APT1 and APT2 confirmed the abundance of mitochondrial APT1 substrates. APT1 activity was further linked to a role in glucose metabolism in mice fed a high-fat diet, a phenotype exacerbated in mice with liver-specific double-knockout of APT1 and APT2 (ref. 111). ABDH10 seems to be involved in regulation of mitochondrial redox homeostasis <ref type="bibr" target="#b100">100</ref> .</p><p>Although the regulatory deacylation enzymes are topologically cytosolic, they accumulate via their own S-acylation on specific membranes -the Golgi for APT2 (refs. 48,112,113) and the plasma membrane for ABHD17A-ABHD17C (refs. 101-103). When non-acylated, localization of these enzymes is determined by diffusion, whereas localization of their S-acetylated forms is driven by vesicular transport. Moreover, these cytosolic thioesterases undergo dynamic acylationdeacylation cycles. For example, APT2 on the Golgi is S-acylated by ZDHHC3, whereas APT2 on the endoplasmic reticulum is S-acylated by ZDHHC7 (ref. 48), thereby enabling APT2 to potentially be trafficked to the Golgi by vesicular transport. Accumulation of APT2 at the Golgi indicates that it undergoes slow vesicular transport out of this compartment and slow release by deacylation. Slow transport to the plasma membrane, where some APT2 targets reside, does indeed occur <ref type="bibr" target="#b112">112</ref> . At the plasma membrane surface, APT2 is thought to undergo deacylation by an as yet unidentified thioesterase to reinitiate the trafficking cycle <ref type="bibr" target="#b3">4,</ref><ref type="bibr" target="#b112">112</ref> . Understanding how APTs and ABHDs reach different endomembranes to access their substrates requires further investigation.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Regulation and specificity</head><p>Only few regulatory features of APT activity are known. In cells, APT2 activity requires stable association with a membrane, which requires S-acylation of APT2 near its N terminus <ref type="bibr" target="#b48">48</ref> . In the membrane-bound state, APT2 inserts a hydrophobic loop, the β-tongue, into the lipid bilayer. This event masks a lysine residue in APT2 that in the unbound state undergoes ubiquitylation, thereby targeting APT2 for proteasomal degradation <ref type="bibr" target="#b48">48</ref> . Therefore, S-acylation and ubiquitylation control the APT2 pool size as well as its localization and activity. Cytosolic APT1 also undergoes S-acylation <ref type="bibr" target="#b112">112</ref> . In addition, activation of WNT5A signalling induces phosphorylation of two exposed serine residues, which enhances the activity of APT1 and promotes metastatic behaviour of tumour cells <ref type="bibr" target="#b114">114</ref> . Mutation of one of these serines is frequent in human melanoma and is associated with high tumour grade.</p><p>Deacylation enzymes possess unique structural features around their active sites that enable isoform-specific inhibition despite the similarity of their acyl-binding elements <ref type="bibr" target="#b98">98</ref> . Sequence elements in their protein substrates, particularly residues adjacent to the acylated cysteine(s), also influence deacylase specificity <ref type="bibr" target="#b115">115</ref> . Non-redundancy among deacylation enzymes is emphasized by their distinct cellular and tissue expression patterns <ref type="bibr" target="#b116">116</ref> and specific substrates <ref type="bibr" target="#b101">101</ref> . For example, ABHD17A can deacylate both GTPase N-Ras and PSD95, which APT1 and APT2 are unable to modify <ref type="bibr" target="#b101">[101]</ref><ref type="bibr" target="#b102">[102]</ref><ref type="bibr" target="#b103">[103]</ref> . APT1 and APT2 display mostly specific substrates <ref type="bibr" target="#b115">115</ref> , although some studies report that they can have compensatory roles <ref type="bibr" target="#b111">111,</ref><ref type="bibr" target="#b117">117</ref> .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Inhibitors and activity probes</head><p>In contrast to the paucity of ZDHHC inhibitors, numerous small mole cules are available for both inhibiting and monitoring thioesterases in living systems. Among these, the most frequently utilized is palmostatin B <ref type="bibr" target="#b118">118</ref> , a pan-deacylation enzyme covalent inhibitor. Isoform-selective inhibitors are also available that can target APT1 (ML348) <ref type="bibr" target="#b119">119</ref> , APT2 (ML349) <ref type="bibr" target="#b98">98,</ref><ref type="bibr" target="#b120">120</ref> and the three ABHD17 enzymes (the covalent inhibitor AB957) <ref type="bibr" target="#b103">103</ref> . A lipid-based covalent inhibitor that localizes to mitochondria (mitoFP) led to the identification of ABHD10 (ref. 100). Real-time deacylation enzyme activity can be monitored within live cells, for example using inducible fluorescent depalmitoylation probes <ref type="bibr" target="#b100">100,</ref><ref type="bibr" target="#b114">114,</ref><ref type="bibr" target="#b121">[121]</ref><ref type="bibr" target="#b122">[122]</ref><ref type="bibr" target="#b123">[123]</ref><ref type="bibr" target="#b124">[124]</ref><ref type="bibr" target="#b125">[125]</ref> . Studies using such sensing probes <ref type="bibr" target="#b126">126</ref> have revealed that the activity levels of deacylation enzymes are not static but, rather, respond dynamically to signalling events such as epidermal growth factor (EGF) stimulation <ref type="bibr" target="#b121">121</ref> , Wnt signalling <ref type="bibr" target="#b114">114</ref> , tumour necrosis factor receptor 1 (TNFR1) signalling <ref type="bibr" target="#b124">124</ref> , hyperglycaemia <ref type="bibr" target="#b122">122</ref> , palmitate stress <ref type="bibr" target="#b109">109</ref> and redox stress <ref type="bibr" target="#b100">100</ref> . Therefore, the deacylation enzymes themselves seem to be regulated by and able to respond dynamically to cellular cues.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Effects of S-acylation on proteins</head><p>At the individual protein level, the direct effects of S-acylation are arguably limited to two often-interlinked primary outcomes: association with specific membrane domains (Fig. <ref type="figure" target="#fig_3">2a</ref>) and alterations in local protein structure (Fig. <ref type="figure" target="#fig_3">2b</ref>). These elements can instigate several types of secondary and tertiary effects, including relocation to membrane structures with a distinct curvature or thickness (Fig. <ref type="figure" target="#fig_3">2c</ref>); binding to or separation from other membrane or peripheral proteins (Fig. <ref type="figure" target="#fig_3">2d</ref>); and alterations to the protein's activity (Fig. <ref type="figure" target="#fig_3">2h</ref>). In turn, these changes could, collectively or individually, lead to a non-exhaustive range of tertiary consequences that are often, again, interconnected: vesicular trafficking to specific locations in the endomembrane system, such as the plasma membrane or lysosomes (Fig. <ref type="figure" target="#fig_3">2e</ref>); the establishment of protein complexes and signalling platforms (Fig. <ref type="figure" target="#fig_3">2f,</ref><ref type="figure">g</ref>); changes in protein activity and/or function (Fig. <ref type="figure" target="#fig_3">2h</ref>); and interaction with other post-translational modifications, such as ubiquitylation and phosphorylation (Fig. <ref type="figure" target="#fig_3">2i</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Membrane nanodomains</head><p>S-Acylation of soluble proteins causes them to bind to membranes (Fig. <ref type="figure" target="#fig_3">2a</ref>). It is important to note that these proteins generally require an additional mechanism for membrane interaction, which brings them close to the ZDHHC catalytic sites. This mechanism can be a membrane-interacting sequence or another form of lipidation, such as myristoylation <ref type="bibr" target="#b127">127,</ref><ref type="bibr" target="#b128">128</ref> . However, many reported S-acylation substrates are transmembrane proteins <ref type="bibr" target="#b3">4,</ref><ref type="bibr" target="#b14">15</ref> . When acylation occurs on a cytosolic domain, this domain is brought to the membrane, similar to the acylation of soluble proteins <ref type="bibr" target="#b48">48</ref> (Fig. <ref type="figure" target="#fig_3">2a,</ref><ref type="figure">b</ref>). Acylation sites often reside very close to transmembrane domains <ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b42">42</ref> (Fig. <ref type="figure" target="#fig_3">2a,</ref><ref type="figure">b</ref>), sometimes even within them. The addition of the saturated acyl chain influences the</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Review article</head><p>affinity of the transmembrane region for specific lipids, particularly ones that form ordered phases, such as cholesterol, sphingolipids and phospholipids with long saturated acyl chains <ref type="bibr" target="#b129">[129]</ref><ref type="bibr" target="#b130">[130]</ref><ref type="bibr" target="#b131">[131]</ref> .</p><p>Proteins that have a high number of S-acylated cysteines near the membrane -such as the SARS-CoV-2 spike protein, which forms trimers and carries ten acylation sites per protomer -could potentially induce the de novo formation of membrane nanodomains (rather than simply associating with pre-existing ones) through a phase-separation mechanism <ref type="bibr" target="#b52">52</ref> . Therefore, S-acylation ensures the association of a protein with specific nanodomains within a membrane. This specificity guarantees the precise spatial control of mediated events and a high local concentration of the required components, including signalling lipids.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Protein conformation</head><p>S-Acylation, similar to other protein modifications, can directly or indirectly induce conformational changes (Fig. <ref type="figure" target="#fig_3">2b</ref>) that potentially alter the activity of the target protein. For instance, S-acylation can modulate the opening and closing of membrane channels <ref type="bibr" target="#b131">[131]</ref><ref type="bibr" target="#b132">[132]</ref><ref type="bibr" target="#b133">[133]</ref><ref type="bibr" target="#b134">[134]</ref><ref type="bibr" target="#b135">[135]</ref> (Fig. <ref type="figure" target="#fig_3">2h</ref>).</p><p>Various subtypes of voltage-gated sodium (Na V ) channels can undergo S-acylation on two or more cysteines in an intracellular loop, which leads to functional changes in their gating kinetics <ref type="bibr" target="#b132">132</ref> . In cardiac Na V 1.5 channels, for example, mutation of one of the four putative S-acylation sites affects both voltage dependence and channel inactivation; these changes have been linked to cardiac arrhythmia <ref type="bibr" target="#b133">133</ref> . Similar alterations in voltage sensitivity and tarantula toxin reactivity are observed in Na V 1.2 channels with mutations in S-acylation sites <ref type="bibr" target="#b134">134</ref> , which suggests that S-acylation-induced conformational changes also influence regions beyond the voltage-sensing domain.</p><p>S-Acylation can also tilt transmembrane domains <ref type="bibr" target="#b136">136,</ref><ref type="bibr" target="#b137">137</ref> , such as those of the Wnt co-receptor low-density lipoprotein receptor-related protein 6 (LRP6). After synthesis in the endoplasmic reticulum, LRP6 folds and then moves to the Golgi and, ultimately, the cell surface. The transmembrane domain length of LRP6 is a good match for the plasma membrane thickness but is too long for the thinner endoplasmic reticulum membrane. S-Acylation-induced transmembrane domain tilting compensates for this hydrophobic mismatch <ref type="bibr" target="#b137">137</ref> . In addition to preventing premature targeting to the endoplasmic </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Review article</head><p>reticulum-associated degradation pathway, such mechanisms could potentially enable S-acylation to play a crucial role in the biogenesis of transmembrane proteins <ref type="bibr" target="#b14">15</ref> .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Subcellular protein localization</head><p>S-Acylation-induced alterations in the physical and chemical properties of proteins might lead to their movement into membrane regions with different thicknesses and/or curvatures, such as the nuclear envelope, endoplasmic reticulum, endosomal tubules and budding sites of vesicular transport intermediates (Fig. <ref type="figure" target="#fig_3">2c</ref>). For example, S-acylation of LRP6 is required for its association with endoplasmic reticulum exit sites and transport to the Golgi <ref type="bibr" target="#b138">138</ref> . S-Acylated proteins concentrate into curved regions at the Golgi rims, which enables their anterograde trafficking to the plasma membrane <ref type="bibr" target="#b63">63</ref> . The small GTPase ADP-ribosylation factor 6 (ARF6) mediates the transport of S-acylated proteins, such as the EGF receptor (EGFR) <ref type="bibr" target="#b139">139</ref> and the fatty acid transporter CD36 (ref. 140), out of the Golgi. Regardless of any conformational changes, S-acylation could promote interactions between cargo proteins and the armada of proteins that regulate membrane trafficking (Fig. <ref type="figure" target="#fig_3">2e</ref>). In particular, S-acylation and deacylation cycles might positively or negatively regulate the endocytosis and targeting to lysosomes of numerous receptors, thereby fine-tuning their surface abundance <ref type="bibr" target="#b50">50,</ref><ref type="bibr" target="#b117">117,</ref><ref type="bibr" target="#b124">124,</ref><ref type="bibr" target="#b141">[141]</ref><ref type="bibr" target="#b142">[142]</ref><ref type="bibr" target="#b143">[143]</ref><ref type="bibr" target="#b144">[144]</ref><ref type="bibr" target="#b145">[145]</ref> . Through mechanisms that remain to be identified, S-acylation could also promote or inhibit the association of proteins with nascent transport vesicles and/or various regulators of membrane trafficking. The influence of S-acylation in protein localization is accentuated by the fact that many proteins involved in regulation of vesicular trafficking also require acylation, including small GTPases of the Rho family and various SNAREs <ref type="bibr" target="#b21">22,</ref><ref type="bibr" target="#b146">[146]</ref><ref type="bibr" target="#b147">[147]</ref><ref type="bibr" target="#b148">[148]</ref> .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Formation of multiprotein complexes</head><p>Signalling at the plasma membrane provides a compelling illustration of the importance of precisely recruiting and/or producing specific proteins and lipids at designated sites. Extracellular stimuli activate specific receptors that converge on a limited set of shared signalling molecules, such as the Src-family kinases, RACα serine/threonine-protein kinase (AKT), AMP-activated protein kinase (AMPK) and the serine/ threonine-protein kinase mTOR. Nonetheless, the cellular response finely matches the initial stimulus. Localized sequential recruitment and activation of proteins at the membrane-cytosol interface ensure this response specificity, and S-acylation is well suited for orchestrating both the reversible lateral organization of membrane domains and the association of cytosolic proteins with these domains. The molecular underpinnings of the role of S-acylation in signal propagation is beginning to be uncovered. Stimulus-induced cycles of S-acylation and deacylation (in which, for example, a signal might trigger S-acylation of a receptor that is then internalized and subsequently deacylated) have indeed been observed for signalling through growth factor receptors <ref type="bibr" target="#b149">149,</ref><ref type="bibr" target="#b150">150</ref> , G-protein-coupled receptors <ref type="bibr" target="#b151">151,</ref><ref type="bibr" target="#b152">152</ref> , T cell receptors <ref type="bibr" target="#b153">153</ref> and cytokine receptors <ref type="bibr" target="#b64">64</ref> . The formation of multiprotein complexes at membrane interfaces has implications well beyond signalling pathways. Such platforms also mediate functional interactions between the membranes of two distinct cells, as in neuronal or immunological synapses, or between the membranes of different organelles, such as endoplasmic reticulum-plasma membrane and endoplasmic reticulum-mitochondria membrane contact sites <ref type="bibr" target="#b7">8,</ref><ref type="bibr" target="#b14">15</ref> . For example, when calcium levels in the endoplasmic reticulum are too low, the transmembrane endoplasmic reticulum calcium sensor stromal interaction molecule 1 (STIM1) adopts an extended conformation that enables it to interact with and activate calcium release-activated calcium channel protein 1 (ORAI1)-containing calcium channels at endoplasmic reticulum-plasma membrane contact sites. Assembly of STIM1-ORAI1 complexes requires S-acylation of both STIM1 and ORAI1 (refs. 154-156). This lipid modification affects both the membrane nanodomain localization and conformation of these two proteins, thereby facilitating their interaction.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Crosstalk with other modifications</head><p>Coordination of signalling events demands the precise orchestration of various proteins and necessitates that each protein possesses 'evolving' properties; that is, ones mediated by multiple sequential and reversible post-translational modifications that can also influence each other. Indeed, S-acylation can be influenced by many other post-translational modifications of cysteine residues, such as S-nitrosylation 157 and oxidation <ref type="bibr" target="#b158">158</ref> . Furthermore, S-acylation both influences and is influenced by phosphorylation <ref type="bibr" target="#b38">38</ref> , ubiquitylation <ref type="bibr" target="#b18">19,</ref><ref type="bibr" target="#b137">137,</ref><ref type="bibr" target="#b143">143</ref> , methylation, acetylation <ref type="bibr" target="#b77">77</ref> and succinylation <ref type="bibr" target="#b159">159</ref> . However, these documented interactions are likely to be only the tip of the iceberg <ref type="bibr" target="#b77">77,</ref><ref type="bibr" target="#b160">160,</ref><ref type="bibr" target="#b161">161</ref> . Illustrative examples of such crosstalk are mentioned throughout this Review, for example those involving ZDHHC5, APT2 and LRP6.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cellular and physiological processes</head><p>Given that S-acylation affects the ability of proteins to interact with one another at membrane interfaces, it is not surprising that this post-translational modification influences many cellular processes, including endothelial cell and cardiac cell function <ref type="bibr" target="#b10">11</ref> as well as cell adhesion, growth and division. The function of adhesion molecules <ref type="bibr" target="#b162">[162]</ref><ref type="bibr" target="#b163">[163]</ref><ref type="bibr" target="#b164">[164]</ref><ref type="bibr" target="#b165">[165]</ref> , claudins <ref type="bibr" target="#b166">166</ref> and desmosomal proteins <ref type="bibr" target="#b75">75</ref> depends on S-acylation. The dramatic reorganization of the cytoskeleton (both the actomyosin network and microtubules) required for cell division also relies on acylation-deacylation cycles of proteins such as protocadherin 7 (ref. 167) and tubulin <ref type="bibr" target="#b168">168</ref> . Among the many possible options, in this Review we focus on how S-acylation can regulate and be regulated by signalling receptors, given their crucial upstream involvement in many cellular processes. We also discuss important contributions of S-acylation to autophagy, metabolism, innate immunity and brain function.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Signalling receptors</head><p>The intricate relationship between S-acylation and signalling is beautifully illustrated in the heart, in which ZDHHC5 is a key player <ref type="bibr" target="#b78">78</ref> . Cardiac contractility is stimulated by the activation of β-adrenergic receptors (β-ARs). In cardiomyocytes, β-AR agonist treatment leads to a rapid and transient increase in ZDHHC5-mediated S-acylation of Gα coupled to β-AR <ref type="bibr" target="#b152">152</ref> . The kinetics of Gα S-acylation correlates with the timing of cAMP production and with cardiomyocyte contractile responses. Interestingly, β-AR agonist treatment also increases S-acylation of ZDHHC5 at its C-terminal cysteines <ref type="bibr" target="#b78">78</ref> . Although ZDHHC20 was not investigated in this study, it might also participate in this signalling pathway as ZDHHC20 is responsible for ZDHHC5 acylation <ref type="bibr" target="#b76">76</ref> , which stabilizes ZDHHC5 at the plasma membrane and thereby maintains its proximity to components of the β-AR signalling module within membrane nanodomains <ref type="bibr" target="#b38">38,</ref><ref type="bibr" target="#b169">169</ref> .</p><p>ZDHHC5 is also involved in insulin-dependent regulation of sodium-calcium exchanger 1 (NCX1) <ref type="bibr" target="#b149">149</ref> . NCX1 undergoes S-acylation on an intracellular loop flanked by multiple transmembrane domains, which triggers a conformational change that leads to its inactivation. Insulin stimulates the activity of ZDHHC5 by triggering acylation of its</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Review article</head><p>active-site cysteine. Moreover, insulin is well known to trigger fatty acid and fatty acyl-CoA synthesis, which could contribute to the increased S-acylation of ZDHHC5. Indeed, blocking long fatty acyl-CoA synthetase with the inhibitor triacsin C abrogated insulin-stimulated acylation of ZDHHC5, and consequently maintained NCX1 activity. These findings highlight the importance of considering regulation of S-acylation by acyl-CoA availability.</p><p>Many 'promiscuous' signalling molecules, such as the Src-like kinases, AKT and AMPKs, also undergo cycles of acylation and deacylation. Acylation can localize these proteins on membrane surfaces and might additionally control the shuttling of some proteins between the cytoplasm and the nucleus. Signal transducer and activator of transcription 3 (STAT3) can be acylated by ZDHHC7, leading to its cell membrane association <ref type="bibr" target="#b64">64</ref> . When cells are stimulated with growth factors or interferons, STAT3 is phosphorylated, which converts it into a substrate of APT2. Deacylation of STAT3 enables its release from the plasma membrane and transport into the nucleus, where STAT3 can switch on a transcriptional response. STAT3 is also required for the differentiation of T helper 17 cells (T H 17) cells. T H 17 cell overactivation leads to autoinflammatory disorders, such as inflammatory bowel disease. Accordingly, APT2 inhibitors such as ML349 could be of therapeutic interest in these disorders <ref type="bibr" target="#b64">64</ref> (Tables <ref type="table">1</ref> and<ref type="table">2</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Autophagy</head><p>Maintenance of cellular homeostasis demands the efficient and precisely regulated clearance of damaged proteins and organelles. Autophagy plays an important part in this process, and can even take over when the proteasome system is overwhelmed <ref type="bibr" target="#b170">[170]</ref><ref type="bibr" target="#b171">[171]</ref><ref type="bibr" target="#b172">[172]</ref> . Autophagy is an intricate process that involves numerous molecules that recognize damaged proteins or organelles, generate autophagosomes to encapsulate them and mediate their subsequent fusion with lysosomes. A role for S-acylation in autophagy <ref type="bibr" target="#b173">173</ref> is increasingly recognized, particularly in the context of neurodegeneration <ref type="bibr" target="#b21">22</ref> . Several soluble autophagy regulators, such as huntingtin <ref type="bibr" target="#b174">174</ref> , AKT <ref type="bibr" target="#b175">175</ref> , ragulator complex</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Review article</head><p>protein LAMTOR1 and mTOR <ref type="bibr" target="#b176">176</ref> transition from the cytosol to cell membranes after S-acylation. The important autophagy receptor sequestosome 1 (SQSTM1; also known as ubiquitin-binding protein p62) also undergoes acylation <ref type="bibr" target="#b177">177,</ref><ref type="bibr" target="#b178">178</ref> . Upon autophagy induction, p62 binds to ubiquitylated proteins that are earmarked for degradation, forming p62 condensates. Their subsequent recruitment to LC3 + autophagocytic membranes depends on ZDHHC19-mediated acylation of p62 (ref. 178). Preventing p62 deacylation by APT1 leads to increased autophagic flux and enhanced protein clearance <ref type="bibr" target="#b178">178</ref> . This finding aligns with observations of reduced p62 acylation in mice and patients with Huntington disease <ref type="bibr" target="#b177">177</ref> , which suggests that elevating p62 acylation levels might have therapeutic potential in some neurodegenerative diseases.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Fatty acid and glucose uptake</head><p>Insulin, which stimulates fatty acid and glucose uptake, is secreted by pancreatic β-cells in response to high blood glucose levels in a multistep process that heavily relies on S-acylated proteins <ref type="bibr" target="#b179">179</ref> . However, the extent of S-acylation must be finely tuned to avoid excessive as well as insufficient acylation. For example, mice with APT1 deficiency have hyperinsulinaemia, which is linked to type 2 diabetes mellitus <ref type="bibr" target="#b180">180</ref> . The underlying defect was pinpointed as altered secretory vesicle </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Review article</head><p>trafficking, which prolonged membrane fusion. SCAMP1 (secretory carrier-associated membrane protein 1) was identified as the substrate of APT1 responsible for this effect, as hyperinsulinaemia could be rescued by an acylation-deficient SCAMP1 mutant <ref type="bibr" target="#b122">122</ref> . Fatty acids are essential for S-acylation as they are substrates for acyl-CoA synthetase <ref type="bibr" target="#b181">181</ref> , although acyl-CoAs can also be produced de novo through the action of fatty acid synthase (FASN). Fatty acid uptake primarily relies on the translocase CD36 (ref. 182), which spans the membrane twice and includes a large luminal (or extracellular) fatty acid binding domain along with cytoplasmic N and C termini (Fig. <ref type="figure" target="#fig_6">4a</ref>). Each CD36 transmembrane domain has two juxtamembranous cytosolic cysteines that undergo S-acylation <ref type="bibr" target="#b182">182</ref> in the endoplasmic reticulum by ZDHHC4 (ref. 183), ZDHHC7 (ref. 184) or ZDHHC6 with the help of its cofactor SelK <ref type="bibr" target="#b185">185,</ref><ref type="bibr" target="#b186">186</ref> . S-Acylation of CD36 is required for its efficient folding and transport through the secretory pathway <ref type="bibr" target="#b139">139,</ref><ref type="bibr" target="#b140">140,</ref><ref type="bibr" target="#b183">183</ref> . Around 50% of CD36 reaches the plasma membrane constitutively but insulin stimulation augments surface levels of CD36 via delivery from intracellular stores. At the plasma membrane, ZDHHC5-mediated S-acylation of CD36 controls its localization in nanodomains, and is counteracted by APT1-mediated constitutive deacylation <ref type="bibr" target="#b140">140,</ref><ref type="bibr" target="#b183">183,</ref><ref type="bibr" target="#b187">187</ref> . S-Acylation is also essential for the lipid uptake capacity of CD36 and for the activation of downstream signalling mediators, such as tyrosine-protein kinases LYN, FYN and c-Jun N-terminal kinase <ref type="bibr" target="#b186">186</ref> . Binding of extracellular fatty acids triggers APT1-mediated deacylation and endocytosis of CD36, thereby enabling intracellular delivery of its lipid cargo. CD36 is then re-acylated by ZDHHC5 and recycled to the plasma membrane for another round of fatty acid uptake <ref type="bibr" target="#b188">188</ref> . This dynamic acylation-deacylation cycle is highly regulated. Fatty acid binding also provides a negative feedback loop initiated by activation of the Src kinase LYN, which subsequently phosphorylates Tyr91 of ZDHHC5, thereby inhibiting its activity.</p><p>Insulin secretion triggers glucose uptake, which is mediated by facilitative transporters such as glucose transporter 4 (GLUT4). Similar to CD36, GLUT4 is sequestered in the endosomal-trans-Golgi network system under basal conditions. Upon insulin stimulation, GLUT4 is transported to the plasma membrane in a ZDHHC7-dependent manner <ref type="bibr" target="#b189">189</ref> . Mice with knockout of zDHHC7 consistently display hyperglycaemia and impaired glucose tolerance, which are characteristics of type 2 diabetes mellitus <ref type="bibr" target="#b190">190</ref> (Tables <ref type="table">1</ref> and<ref type="table">2</ref>).</p><p>Transport of both CD36 and GLUT4 to the cell surface is controlled by AMPK and AKT. In response to energy stress, AMPK, AKT and the AKT modulator CAP-Gly domain-containing linker protein 3 (also known as cytoplasmic linker protein 170-related 59 kDa protein (CLIPR-59)) are recruited to the plasma membrane in a manner predominantly orchestrated by ZDHHC17-mediated S-acylation <ref type="bibr" target="#b175">175,</ref><ref type="bibr" target="#b191">[191]</ref><ref type="bibr" target="#b192">[192]</ref><ref type="bibr" target="#b193">[193]</ref> .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Innate immunity</head><p>Pathogen-associated molecular patterns (PAMPs) and damageassociated molecular patterns (DAMPs) are detected in cells by various sensors present either at the membrane surface or intracellularly. Tight compartmentalization enables cells to respond to even the lowest concentrations of microbial products with inflammatory and antimicrobial signalling cascades. S-Acylation is emerging as a key regulator of innate immune sensing and signal transduction responses, and alterations in protein S-acylation have been associated with various autoinflammatory disorders <ref type="bibr" target="#b9">10,</ref><ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b64">64,</ref><ref type="bibr" target="#b194">194</ref> (Tables <ref type="table">1</ref> and<ref type="table">2</ref>).</p><p>Three principles have started to emerge (Fig. <ref type="figure" target="#fig_5">3</ref>). The first is that S-acylation ensures that the transmembrane sensors of extracellular microbial products such as Toll-like receptors (TLRs) and the death receptors FAS and TNFR1 are present at the plasma membrane in sufficient amounts and localize to specific nanodomains <ref type="bibr" target="#b9">10,</ref><ref type="bibr" target="#b124">124,</ref><ref type="bibr" target="#b194">194</ref> (Fig. <ref type="figure" target="#fig_5">3a</ref>).</p><p>The second principle is that S-acylation can regulate the ligand-induced formation of signalling platforms and/or complexes (Fig. <ref type="figure" target="#fig_5">3b</ref>). For example, S-acylation of some TLRs and the downstream effector MyD88 are required for nuclear factor-κB (NF-κB) signalling and pro-inflammatory cytokine production <ref type="bibr" target="#b195">195</ref> . S-Acylation of TNFR1 is required for TNF-induced signalling, and the subsequent cellular response is sustained through APT2-mediated deacylation of TNFR1 and its transport to intracellular signalling platforms <ref type="bibr" target="#b124">124</ref> . S-Acylation can also act as a negative regulator of ligand-receptor interactions. For example, TNF is generated from a transmembrane TNF precursor, which is S-acylated to ensure that it does not bind to TNFR1 when both are present at the cell surface, thereby avoiding uncontrolled cell death <ref type="bibr" target="#b196">196</ref> . Signalling in response to cytoplasmic double-stranded DNA also depends on S-acylation of the cytosolic DNA-sensing enzyme cyclic GMP-AMP synthase (cGAS) and the transmembrane protein STING (stimulator of interferon genes), which responds to cyclic GMP-AMP. The enzyme activity of cGAS depends on its dimerization, which is differentially affected by S-acylation of three different cysteines by two different enzymes, ZDHHC9 (ref. 197) and ZDHHC18 (ref. 198). S-Acylation of STING occurs upon its GMP-AMP-induced transport from the endoplasmic reticulum to the Golgi, which enables recruitment of downstream Some Toll-like receptors (TLRs) localize to the cell surface and to specific domains in an S-acylation-dependent manner, as do tumour necrosis factor 1 receptor (TNFR1) and the death receptor Fas. b, S-Acylation influences the ability of various transmembrane and soluble intracellular innate immunity sensors to signal to their downstream effectors. Zinc-finger and aspartatehistidine-histidine-cysteine (DHHC) motif-containing (ZDHHC) enzymes and acyl-protein thioesterases (APTs) identified in each situation are mentioned in parentheses. Signalling through TLRs requires S-acylation of the downstream effector MYD88 (1). S-Acylation of the transmembrane TNF precursor and TNFR1 ensure that the two transmembrane proteins remain segregated in different regions of the plasma membrane, which prevents premature binding of TNF to its receptor. Binding of soluble TNF to its receptor triggers deacylation and endocytosis, which initiates further intracellular signalling (2). The function and dimerization of cyclic GMP-AMP synthase (cGAS) depends on its S-acylation status (3). The cyclic dinucleotides generated by cGAS bind to STING (stimulator of interferon genes) but its ability to signal to downstream effectors once transported to the Golgi depends on its S-acylation (4). The intracellular danger detectors NOD1 and NOD2 (nucleotide-binding oligomerization domain-containing proteins 1 and 2, respectively) must undergo S-acylation before associating with intracellular bacteria-containing membrane-bound structures and inducing appropriate signalling and inflammatory responses (5). c, S-Acylation accelerates or slows down the lysosomal degradation of innate immunity sensors. Stimulus-provoked assembly of the NLRP3 inflammasome induces caspase-1-mediated proteolysis of the pore-forming protein gasdermin D. However, for gasdermin D to oligomerize and puncture membranes it must undergo S-acylation (1). Given the potency of the NLRP3 inflammasome, it must be switched off by S-acylation of NLRP3, which leads to its targeting to lysosomes via chaperone-mediated autophagy (2). S-Acylation of NOD2 also inhibits its targeting to autophagosomes in a p62-dependent manner (3). LYPLA1, lysophospholipase 1.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Review article</head><p>factors and triggering of the transcriptional immune response <ref type="bibr" target="#b199">199,</ref><ref type="bibr" target="#b200">200</ref> . Sensing of cytosolic PAMPs leads to the assembly of the proteolytic inflammasome complex <ref type="bibr" target="#b201">201,</ref><ref type="bibr" target="#b202">202</ref> . NLRP3, which is one of the major sensors leading to inflammasome assembly <ref type="bibr" target="#b203">203</ref> , requires S-acylation in order to oligomerize <ref type="bibr" target="#b204">204</ref> . Finally, the cytosolic sensors NOD1 and NOD2 (nucleotide-binding oligomerization domain-containing proteins 1 and 2, respectively) also rely on S-acylation for their recruitment to bacteria-containing endosomes, which is essential for their ability to sense peptidoglycan and trigger NF-κB and mitogen-activated protein kinase (MAPK) signalling pathways <ref type="bibr" target="#b205">205</ref> .</p><p>The third principle is that S-acylation can also regulate the duration and/or amplitude of innate immune responses (Fig. <ref type="figure" target="#fig_5">3c</ref>). S-Acylation sustains NOD2-mediated signalling by preventing the degradation of NOD2 through p62-mediated autophagy <ref type="bibr" target="#b206">206</ref> . By contrast, S-acylation also inactivates inflammasomes by inducing a conformational change in NLRP3, thereby unmasking a recognition site that targets it for chaperone-mediated autophagy <ref type="bibr" target="#b205">205</ref> . The S-acylation events that precipitate oligomerization occur at different sites in NLRP3 and involve a different ZDHHC enzyme to those associated with S-acylation events leading to inflammasome degradation <ref type="bibr" target="#b202">202,</ref><ref type="bibr" target="#b204">204</ref> . Dampening of the NLRP3 inflammasome is important to reduce the cleavage of gasdermin D, a pore-forming protein that drives inflammatory cell death in a process known as pyroptosis <ref type="bibr" target="#b207">207</ref> . Gasdermins are produced as inactive precursors that undergo processing by the NLRP3 inflammasome. Much research effort has been invested in identifying drugs that block gasdermin pore formation and thereby inhibit pyroptosis. Remarkably, all such agents identified so far affect the same cysteine in gasdermin D <ref type="bibr" target="#b159">159,</ref><ref type="bibr" target="#b208">[208]</ref><ref type="bibr" target="#b209">[209]</ref><ref type="bibr" target="#b210">[210]</ref><ref type="bibr" target="#b211">[211]</ref> , which requires S-acylation for gasdermin D oligomerization and pore formation to occur <ref type="bibr" target="#b212">212,</ref><ref type="bibr" target="#b213">213</ref> . Consistent with this observation, inhibition of deacylation promotes pyroptosis <ref type="bibr" target="#b214">214</ref> .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Brain function</head><p>S-Acylation governs numerous brain processes, including the differentiation and maturation of diverse brain cell types <ref type="bibr" target="#b215">[215]</ref><ref type="bibr" target="#b216">[216]</ref><ref type="bibr" target="#b217">[217]</ref> , neural circuit formation during development <ref type="bibr" target="#b218">[218]</ref><ref type="bibr" target="#b219">[219]</ref><ref type="bibr" target="#b220">[220]</ref> and modulation of neuronal plasticity <ref type="bibr" target="#b221">[221]</ref><ref type="bibr" target="#b222">[222]</ref><ref type="bibr" target="#b223">[223]</ref><ref type="bibr" target="#b224">[224]</ref><ref type="bibr" target="#b225">[225]</ref> . As a consequence, balanced S-acylation is essential for learning, memory and appropriate behavioural responses <ref type="bibr" target="#b217">217,</ref><ref type="bibr" target="#b221">221,</ref><ref type="bibr" target="#b222">222,</ref><ref type="bibr" target="#b226">226,</ref><ref type="bibr" target="#b227">227</ref> . In the brain, S-acylation is particularly dynamic and responds to stress <ref type="bibr" target="#b157">157</ref> , learning events <ref type="bibr" target="#b228">228</ref> and synaptic activity <ref type="bibr" target="#b56">56,</ref><ref type="bibr" target="#b57">57,</ref><ref type="bibr" target="#b80">80,</ref><ref type="bibr" target="#b222">222,</ref><ref type="bibr" target="#b225">225,</ref><ref type="bibr" target="#b229">229,</ref><ref type="bibr" target="#b230">230</ref> . As in other tissues, S-acylation in the brain involves post-translational modification of ZDHHC enzymes, which alters their stability, function and/or subcellular localization <ref type="bibr" target="#b77">77,</ref><ref type="bibr" target="#b80">80</ref> .</p><p>At the cellular level, S-acylation has been studied mostly in neurons (Fig. <ref type="figure" target="#fig_6">4b</ref>) where it regulates neuronal development, axon and dendrite growth, and also promotes the precise targeting and clustering of Na V and voltage-gated potassium channels to the axon initial segment <ref type="bibr" target="#b231">231</ref> , thereby regulating neuronal excitability. Approximately 45% of all synaptic proteins are substrates for S-acylation, including adhesion molecules, synaptic vesicle release machinery, signalling molecules, neurotransmitter receptors, scaffold proteins and kinases <ref type="bibr" target="#b221">221,</ref><ref type="bibr" target="#b226">226,</ref><ref type="bibr" target="#b232">232</ref> . In addition, strong evidence indicates that S-acylation regulates the formation and plasticity of synapses. S-Acylation, therefore, directly regulates neural output and communication. Oligodendrocytes depend on S-acylation for their maturation <ref type="bibr" target="#b217">217,</ref><ref type="bibr" target="#b233">233</ref> and their ability to form the myelin sheaths that wrap around axons and support efficient neuronal function <ref type="bibr" target="#b217">217,</ref><ref type="bibr" target="#b234">234</ref> . The importance of S-acylation in myelin formation is further bolstered by SwissPalm data showing that almost all of the myelin proteome (94% in mice, 83% in humans) could be substrates for S-acylation.</p><p>Virtually all known S-acylating enzymes are expressed in the brain <ref type="bibr" target="#b44">44</ref> (Box 1), where they have unique spatial and developmental patterns of expression that affect their substrate specificity and regulate their function. Although it is unclear which enzymes are involved in many of the aforementioned processes, the role of a subset of enzymes in the brain has been described (Fig. <ref type="figure" target="#fig_6">4b</ref>).</p><p>Alterations in S-acylation, deacylation and the balance between the two have a pathogenetic role in disorders of the nervous system, inflammatory and immune diseases, metabolic disorders (such as diabetes and obesity) and many types of cancer <ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref> (Tables <ref type="table">1</ref> and<ref type="table">2</ref>). Mutations in ZDHHCs and acyl-thioesterases or in their target proteins resulting in diminished acylation can also contribute to disease. Interestingly, proteins can also acquire deleterious gain-of-acylation mutations. For example, a gain-of-acylation mutation in cell division control protein 42 homologue (CDC42), a Rho-family GTPase, led to severe autoinflammatory syndrome <ref type="bibr" target="#b235">235</ref> . Although S-acylation contributes to many diseases, in this Review we specifically focus on cancer and brain disorders. Cancer is particularly interesting owing to its intersection with both signalling and immunity, and a wealth of information is available on the role of S-acylation in higher brain functions.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cancer</head><p>Cancer is driven by alterations in multiple cellular processes such as cell growth, division, polarity, migration, energy metabolism and immune recognition, which all extensively rely on S-acylation <ref type="bibr" target="#b16">17,</ref><ref type="bibr" target="#b17">18</ref> . Regulators of these processes include Ras family GTPases, Src-family kinases, EGFR, MAPK, AKT, protein scribble homologue (SCRIB), mTOR, WNT proteins, Frizzled receptors and LRP6 (refs. 17,18). Understanding Ras acylation-deacylation cycles has been an important driving force in S-acylation research <ref type="bibr" target="#b96">96</ref> . Altered expression of ZDHHC and APT enzymes affects cancer progression, which is consistent with a contribution of S-acylation (Tables <ref type="table">1</ref> and<ref type="table">2</ref>). S-Acylation has, therefore, become a promising target for new anticancer therapies <ref type="bibr" target="#b20">21</ref> .</p><p>S-Acylation is implicated in various immune-escape strategies used by tumour cells. ZDHHC20 promotes pancreatic cancer metastasis by altering the surface proteome of tumour cells, which impairs their recognition by natural killer cells <ref type="bibr" target="#b236">236</ref> . Cytotoxic T cells can also kill tumour cells. However, tumour cells exploit a regulatory pathway that prevents these T cells from accidentally killing healthy cells. This pathway involves expression of the transmembrane protein PDL1 on tumour cells, a 'don't kill me' signal that is recognized by its receptor PD1 on T cells. Interaction of PDL1 and PD1 inhibits T cell activation, thus making tumour cells invisible to the immune system. Treatment with antibodies that block this ligand-receptor interaction are highly beneficial in some oncological settings, but many tumours do not respond to such so-called immune checkpoint blockade. However, surface expression of PDL1 is dependent on its acylation by ZDHHC3 (ref. 237)  or ZDHHC9 (ref. 238), which protects PDL1 from ubiquitylation and targeting to lysosomes. Preventing PDL1 acylation, either by cysteine mutagenesis or ZDHHC silencing, led to increased T cell-mediated tumour cell killing <ref type="bibr" target="#b237">[237]</ref><ref type="bibr" target="#b238">[238]</ref><ref type="bibr" target="#b239">[239]</ref> , indicating that promoting S-acylation of PDL1 is a promising strategy to prevent tumour immune evasion. Lipid metabolic enzymes (which influence fatty acid availability and promote the metabolic reprogramming of cancer cells) might constitute additional potential therapeutic targets.</p><p>Tumour cell death can also be triggered by pyroptosis <ref type="bibr" target="#b240">240</ref> , although this process requires efficient checkpoints if it is not to accidentally kill healthy cells. Some cancer treatments induce pyroptosis, which leads to the release of inflammatory molecules that promote Review article lymphocyte recruitment and favour clearance of tumour cells by the immune system. As gasdermins require S-acylation for pore formation, S-acylation-promoting treatments are of great interest in this context <ref type="bibr" target="#b241">241</ref> . Pyroptosis might also enhance the antitumour efficacy of immune checkpoint inhibitors.</p><p>Tumour cells can also evade innate immune surveillance by downregulating STING, which detects cytosolic DNA originating from damaged micronuclei <ref type="bibr" target="#b242">242,</ref><ref type="bibr" target="#b243">243</ref> . Levels of STING protein are greatly decreased in gastric cancers <ref type="bibr" target="#b244">244</ref> . Thus, increasing S-acylation of STING, which both stabilizes this protein and promotes its capacity to trigger an immune response, might have therapeutic potential. Finally, tumour progression could be inhibited by reducing the glucose supply necessary for tumorigenesis. Targeting ZDHHC9, the enzyme responsible for acylation and plasma membrane localization of GLUT1, reduced tumorigenesis by decreasing glucose availability in glioblastoma cells <ref type="bibr" target="#b245">245</ref> .</p><p>Excitatory synapse plasticity: </p><formula xml:id="formula_4">• ZDHHC2 • ZDHHC5 • ZDHHC7 • APT1 • ABHD17 Dendrite outgrowth: • ZDHHC7 • ZDHHC9 • ZDHHC15 Clustering of axon initial segment (AIS) proteins: • ZDHHC14 Inhibitory synapse formation: • ZDHHC9 Oligodendrocyte maturation: • ZDHHC5 • ZDHHC9 Injury-induced axon degeneration: • ZDHHC17 Axon outgrowth: • ZDHHC7 • ZDHHC8 • ZDHHC5 • ZDHHC9 Excitatory synapse formation: • ZDHHC5 • ZDHHC7 • ZDHHC8 • ZDHHC15 • PPT1 ZDHHC5 ZDHHC5 ZDHHC4, ZDHHC6<label>,</label></formula></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Review article</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Diseases of the central nervous system</head><p>Dysregulated S-acylation has been implicated in numerous brain diseases, including neurodegenerative and neurodevelopmental disorders (Table <ref type="table">1</ref>). The association between S-acylation and neurodegenerative disorders is tenuous and primarily lies in the S-acylation-mediated regulation of key disease-associated proteins, including huntingtin (Huntington disease) <ref type="bibr" target="#b246">[246]</ref><ref type="bibr" target="#b247">[247]</ref><ref type="bibr" target="#b248">[248]</ref><ref type="bibr" target="#b249">[249]</ref> , α-synuclein (Parkinson disease) <ref type="bibr" target="#b250">250,</ref><ref type="bibr" target="#b251">251</ref> and amyloid precursor protein (Alzheimer disease) <ref type="bibr" target="#b252">252,</ref><ref type="bibr" target="#b253">253</ref> . In fact, widespread changes in protein S-acylation have been identified in the cortices of patients with Parkinson disease <ref type="bibr" target="#b254">254</ref> , and a variant of ZDHHC21 was identified in a family with familial Alzheimer disease <ref type="bibr" target="#b255">255</ref> . These findings support the possible existence of direct associations between disrupted S-acylation and neurodegenerative disorders.</p><p>By contrast, strong evidence supports a causative role of genetic disruptions in S-acylating enzymes in developmental disorders. ZDHHC9 loss-of-function mutations cause Raymond-type syndromic X-linked intellectual developmental disorder, which is associated with a high incidence of comorbid epilepsy <ref type="bibr" target="#b256">256</ref> . Genetic alterations in ZDHHC15 have been observed in individuals with X-linked intellectual developmental disorder 19 (XLID19) <ref type="bibr" target="#b257">257</ref> , Smith-Magenis syndrome and autism <ref type="bibr" target="#b258">258</ref> . Finally, genetic disruptions in ZDHHC5 (ref. </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusions</head><p>When S-acylation of viral glycoproteins was discovered in the late 1970s (Supplementary Box 1), it was unimaginable that 50 years later S-acylation would emerge as a pivotal post-translational modification used to finely regulate nearly every cellular process with astonishing precision. Such precision is feasible owing to the capacity of S-acylation and deacylation enzymes not only to switch protein function on or off but also to meticulously govern ingress and egress of proteins at membrane interfaces, in terms of both location and timing.</p><p>Despite considerable advances in understanding of protein S-acylation, great challenges lie ahead from both a basic science and a clinical perspective. Of particular interest is the intricate interplay between S-acylation and deacylation enzymes, as correct functioning of most ZDHHCs and acyl-thioesterases requires cycles of acylation and deacylation. Therefore, S-acylation provides a unique opportunity for achieving systems-level functional understanding. In contrast to phosphorylation and ubiquitylation, which are mediated by hundreds to thousands of enzymes, S-acylation involves fewer than 30 enzymes, which offers the fascinating prospect of studies to comprehensively map how each enzyme modifies and is modified by the others. Subsequently, using predictive mathematical models and experimentation, we can evaluate the benefits and purposes of these interconnections. Crosstalk with other post-transcriptional modifications adds another layer of complexity for which only the surface has been scratched so far, and no rules have yet emerged.</p><p>Future challenges include the development of novel inhibitors. Presently, no inhibitors specific to individual ZDHHC enzymes have been identified, unlike those for some deacylation enzymes. The design of inhibitors specific to a given substrate, rather than specific to the modifying enzyme(s), presents an interesting alternative with great potential <ref type="bibr" target="#b200">200</ref> . A crucial missing piece to achieve this goal is a high-resolution structure of a ZDHHC bound to its protein substrate. The field also lacks tools to monitor the acylation status of a protein or to visualize the spatiotemporal dynamics of S-acylation in living cells. For example, no equivalents currently exist of the antibodies that target phosphorylated versions of particular proteins, but conformation-specific recombinant antibodies, such as those developed to recognize the S-acylated form of PSD95 (ref. 261), offer an interesting alternative. A comprehensive view of the targetome of each ZDHHC and deacylation enzyme is also lacking. Artificial intelligence and machine learning approaches could potentially expedite the assignment of ZDHHCs to specific substrates. Other important future avenues include determining how the acyl-proteome of a cell is influenced by extracellular stimuli, such as cytokines, inflammatory mediators or growth factors, as well as the metabolic state of the cell or the organism.</p><p>Nonetheless, the amassed knowledge outlined in this Review serves as a foundation for the development of therapeutics based on S-acylation. Future investigative work is required to determine the therapeutic potential of approaches targeting ZDHHCs and APTs to fight specific diseases. </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Dendritic spines</head><p>Small membrane protrusions that receive input from a single axon at the synapse; similar protrusions can also occur on flat membranes (dendritic shafts). </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Fatty acids</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Hydrophobic mismatch</head><p>A situation where the length of an orthogonal transmembrane helix of a protein differs from (that is, is shorter or longer than) the thickness of a membrane.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Inflammasome</head><p>A multiprotein proteolytic complex that forms in the cytosol in response to sensing of molecules of bacterial origin or danger signals such as low potassium levels; inflammasomes cleave the precursors of IL-1β and gasdermins.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Insulin</head><p>A peptide hormone that regulates glucose homeostasis and has anabolic actions on target tissues that enable the body to build energy reserves when glucose is abundant.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Membrane contact sites</head><p>Sites of membrane juxtaposition between organelles. mTOR A kinase that regulates numerous cellular processes, including cell growth and proliferation, that are important in cancer.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Oligodendrocytes</head><p>Glial cells of the central nervous system whose main function is to insulate the axons of neurons by forming a myelin sheath.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Pyroptosis</head><p>A form of programmed cell death that occurs during inflammation and involves gasdermin pore formation in the cytoplasmic face of the plasma membrane.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Spike protein</head><p>The SARS-CoV-2 viral glycoprotein responsible for its characteristic crown appearance; the spike protein binds to host cells and facilitates fusion of the viral membrane with that of the infected cell.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc>enzymes and cycles. a, Overview of protein S-acylation regulation.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head></head><label></label><figDesc>d , ZDHHC15 a,d , ZDHHC20 a,d , ZDHHC21 a-d Not studied Autoimmune and inflammatory disorders: rheumatoid arthritis, inflammatory bowel disease, psoriasis, vitiligo, ankylosing spondylitis ZDHHC1 a,b , ZDHHC2 a,b , ZDHHC3 a,d , ZDHHC6 a,d , ZDHHC7 a,b,d , ZDHHC8 c,d , ZDHHC16 c , ZDHHC18 b , ZDHHC21 a,b,d APT2 a,d</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head></head><label></label><figDesc>APT1 a,b,d APT2 b , PPT1 a-d Neurodegenerative diseases: Alzheimer disease, Huntington disease, Parkinson disease, multiple sclerosis, prion diseases, CLN1 ZDHHC2 b , ZDHHC6 c , ZDHHC7 b,d , ZDHHC8 b , ZDHHC9 b-d , ZDHHC13 a,b,d , ZDHHC15 b,d , ZDHHC17 a-d , ZDHHC20 b,d , ZDHHC21 a-d APT2 b,d , PPT1 a-d , ABHD17s a,b,d Skin, ear and eye disorders ZDHHC2 a,b,d , ZDHHC3 a,b,d , ZDHHC7 a,b,d , ZDHHC13 a-d , ZDHHC15 a,b,d , ZDHHC20 a-d , ZDHHC21 a-d APT2 a,d Physiological processes Angiogenesis ZDHHC3 a,d , ZDHHC4 a,d APT1 a,b,d , APT2 a,b,d Metabolism: insulin secretion, high-density lipoprotein regulation ZDHHC5 a,d , ZDHHC6 c,d , ZDHHC8 b , ZDHHC17 b,d APT1 a,b,d , APT2 a,b,d Neuronal development ZDHHC3 a,b , ZDHHC5 a-d , ZDHHC7 a,b , ZDHHC8 a,b,d , ZDHHC9 a-d , ZDHHC13 a-d , ZDHHC14 a,b , ZDHHC17 a-d , ZDHHC21 a-d ABHD17s a,b,d , PPT1 a-d Senescence ZDHHC3 a,b,d , ZDHHC7 a,b Not studied Spermatogenesis ZDHHC11 a , ZDHHC19 a,b Not studied</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig. 2 |</head><label>2</label><figDesc>Fig.2| Consequences of protein S-acylation. S-Acylation can be categorized as having primary, secondary and tertiary consequences. a, S-Acylation of a cytosolic protein can promote its association with a membrane, and specifically with a particular type of membrane domain. S-Acylation of a transmembrane protein can move it to a specific membrane nanodomain. b, S-Acylation can trigger changes in a protein's conformation, locally or globally, including of its transmembrane domains. c,d, These primary consequences can lead proteins to move into regions of the membrane that have a different curvature</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Fig. 3 |</head><label>3</label><figDesc>Fig.3| S-Acylation and innate immunity. a, S-Acylation can control the surface abundance and specific localization of receptors involved in innate immunity. Some Toll-like receptors (TLRs) localize to the cell surface and to specific domains in an S-acylation-dependent manner, as do tumour necrosis factor 1 receptor (TNFR1) and the death receptor Fas. b, S-Acylation influences the ability of various transmembrane and soluble intracellular innate immunity sensors to signal to their downstream effectors. Zinc-finger and aspartatehistidine-histidine-cysteine (DHHC) motif-containing (ZDHHC) enzymes and acyl-protein thioesterases (APTs) identified in each situation are mentioned in parentheses. Signalling through TLRs requires S-acylation of the downstream effector MYD88(1). S-Acylation of the transmembrane TNF precursor and TNFR1 ensure that the two transmembrane proteins remain segregated in different regions of the plasma membrane, which prevents premature binding of TNF to its receptor. Binding of soluble TNF to its receptor triggers deacylation and endocytosis, which initiates further intracellular signalling(2). The function and dimerization of cyclic GMP-AMP synthase (cGAS) depends on its S-acylation</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Fig. 4 |</head><label>4</label><figDesc>Fig. 4 | Effect of S-acylation on physiological pathways. a,The fatty acid transporter CD36 has two acylation sites at the cytosolic boundary of each of its two transmembrane domains. S-Acylation of these four sites controls trafficking of CD36 through the secretory and endocytic pathways. The zinc-finger and aspartate-histidine-histidine-cysteine (DHHC) motif-containing (ZDHHC) enzymes ZDHHC4, ZDHHC6, and ZDHHC7 are involved in the biogenesis of CD36 and its constitutive delivery to the plasma membrane(5). Constitutive acylation by ZDHHC5 and deacylation by acyl-protein thioesterase 1 (APT1), which are present at the plasma membrane, control the steady-state cell surface abundance of CD36 (1). ZDHHC5-mediated S-acylation of CD36 also enables its regulated, stimulus-induced delivery to the cell surface from an intracellular</figDesc><graphic coords="16,184.99,400.41,351.12,116.88" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head></head><label></label><figDesc>259) and ZDHHC8 (ref. 260) are associated with schizophrenia.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_8"><head></head><label></label><figDesc>coenzyme A). A group of coenzymes involved in fatty acid metabolism.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_9"><head></head><label></label><figDesc>Carboxylic acids with an aliphatic chain, which are either saturated or unsaturated. S-Acylation mostly adds saturated long-chain carboxylic (fatty) acids with aliphatic tails of 13-21 carbons (chemical formula CH 3 (CH 2 ) n COOH), but can also add unsaturated fatty acids such as arachidonic or oleic acids.</figDesc></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div><head>Acknowledgements</head><p>The authors thank <rs type="person">T. Kawate</rs> for creating original Fig. 1d andA. <rs type="person">R. Wild</rs> for editorial assistance. F.G.v.d.G. and F.S.M. were supported by the <rs type="funder">Swiss National Science Foundation</rs> (<rs type="grantNumber">SNSF-31CA30_196651</rs>, <rs type="grantNumber">SNSF-310030_192608</rs>) and by Carigest SA. B.C.D. was supported by the <rs type="funder">National Institute of General Medical Sciences</rs> of the <rs type="funder">National Institutes of Health (NIH)</rs> (<rs type="grantNumber">R35 GM119840</rs>). S.X.B. is supported by the <rs type="funder">Canadian Institutes for Health Research Foundation</rs> Grant (<rs type="grantNumber">FDN-159907</rs>).</p></div>
			</div>
			<listOrg type="funding">
				<org type="funding" xml:id="_2UWFS3P">
					<idno type="grant-number">SNSF-31CA30_196651</idno>
				</org>
				<org type="funding" xml:id="_vt6xVru">
					<idno type="grant-number">SNSF-310030_192608</idno>
				</org>
				<org type="funding" xml:id="_czYVctX">
					<idno type="grant-number">R35 GM119840</idno>
				</org>
				<org type="funding" xml:id="_vXkcJ5H">
					<idno type="grant-number">FDN-159907</idno>
				</org>
			</listOrg>

			<div type="availability">
<div xmlns="http://www.tei-c.org/ns/1.0"><p>https://brainpalmseq.med.ubc.ca/ CellPalmSeq: https://cellpalmseq.med.ubc.ca/ SwissPalm: https://swisspalm.org/</p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Review article</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Metabolism</head><p>The non-selective inhibitor 2-bromopalmitate is omitted because it targets all zinc-finger and aspartate-histidine-histidine-cysteine (DHHC) motif-containing (ZDHHC) and acyl-protein thioesterase (APT) enzymes <ref type="bibr" target="#b88">88,</ref><ref type="bibr" target="#b262">262</ref> . Also omitted are ZDHHC24, which is inhibited by cyano-myracrylamide (CMA) <ref type="bibr" target="#b86">86</ref> , and α/β-hydrolase domain-containing protein (ABHD) enzymes that are inhibited by serine hydrolase inhibitors <ref type="bibr" target="#b263">263</ref> but lack mutational and/or phenotypic information. References are indicated in Supplementary Table <ref type="table">2</ref> and provided in the Supplementary Reference. CLN1, neuronal ceroid lipofuscinosis type 1; compound V, 2-(2-hydroxy-5-nitro-benzylidene)-benzo[b]thiophen-3-one; del, deletion; HSV, herpes simplex virus; NA, not available; PPT1, palmitoyl-protein thioesterase 1; SP-PROTAC, stapled peptide proteolysis-targeting chimaera; TTZ, tetrazole-containing compound.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Table 2 (continued) | Phenotypes associated with mouse gene knockouts, human mutations in coding sequences and inhibition of ZDHHC and APT enzymes</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Author contributions</head><p>The authors contributed equally to all aspects of the article.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Competing interests</head><p>The authors declare no competing interests.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Additional information</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supplementary information</head><p>The online version contains supplementary material available at https://doi.org/10.1038/s41580-024-00700-8.</p><p>Peer review information Nature Reviews Molecular Cell Biology thanks Masaki Fukata, Mark Collins and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.</p><p>Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p><p>Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Post-translational modifications in signal integration</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">L</forename><surname>Deribe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Pawson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Dikic</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Struct. Mol. Biol</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="666" to="672" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Evolution and functional cross-talk of protein post-translational modifications</title>
		<author>
			<persName><forename type="first">P</forename><surname>Beltrao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Bork</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Krogan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Van Noort</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Syst. Biol</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">714</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Discovering the landscape of protein modifications</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">K</forename><surname>Keenan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">K</forename><surname>Zachman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Hirschey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Cell</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="page" from="1868" to="1878" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Refining S-acylation: structure, regulation, dynamics, and therapeutic implications</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">U</forename><surname>Anwar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">G</forename><surname>Van Der Goot</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Cell Biol</title>
		<imprint>
			<biblScope unit="volume">222</biblScope>
			<biblScope unit="page">202307103</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Protein lipidation: occurrence, mechanisms, biological functions, and enabling technologies</title>
		<author>
			<persName><forename type="first">H</forename><surname>Jiang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chem. Rev</title>
		<imprint>
			<biblScope unit="volume">118</biblScope>
			<biblScope unit="page" from="919" to="988" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Protein lipidation in cell signaling and diseases: function, regulation, and therapeutic opportunities</title>
		<author>
			<persName><forename type="first">B</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Niu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">K</forename><surname>Jarugumilli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Chem. Biol</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="817" to="831" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">The membrane surface as a platform that organizes cellular and biochemical processes</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Leonard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Loose</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Martens</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Dev. Cell</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page" from="1315" to="1332" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">ER as master regulator of membrane trafficking and organelle function</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Wenzel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Elfmark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Stenmark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Raiborg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Cell Biol</title>
		<imprint>
			<biblScope unit="volume">221</biblScope>
			<biblScope unit="page">202205135</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">The pool of fatty acids covalently bound to platelet proteins by thioester linkages can be altered by exogenously supplied fatty acids</title>
		<author>
			<persName><forename type="first">L</forename><surname>Muszbek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Haramura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Cluette-Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Van Cott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Laposata</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lipids</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="331" to="S337" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Protein cysteine palmitoylation in immunity and inflammation</title>
		<author>
			<persName><forename type="first">H</forename><surname>Lin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FEBS J</title>
		<imprint>
			<biblScope unit="volume">288</biblScope>
			<biblScope unit="page" from="7043" to="7059" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Protein S-palmitoylation: advances and challenges in studying a therapeutically important lipid modification</title>
		<author>
			<persName><forename type="first">A</forename><surname>Main</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Fuller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FEBS J</title>
		<imprint>
			<biblScope unit="volume">289</biblScope>
			<biblScope unit="page" from="861" to="882" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Access and utilization of long chain fatty acyl-CoA by zDHHC protein acyltransferases</title>
		<author>
			<persName><forename type="first">R</forename><surname>Puthenveetil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Gómez-Navarro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Banerjee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr. Opin. Struct. Biol</title>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="page">102463</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Protein acylation: mechanisms, biological functions and therapeutic targets</title>
		<author>
			<persName><forename type="first">S</forename><surname>Shang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Hua</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Signal. Transduct. Target. Ther</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">396</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<monogr>
		<author>
			<persName><forename type="first">M</forename><surname>Blanc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">P A</forename><surname>David</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">G</forename><surname>Van Der Goot</surname></persName>
		</author>
		<title level="m">Protein Lipidation: Methods and Protocols</title>
		<editor>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Linder</surname></persName>
		</editor>
		<imprint>
			<publisher>Springer</publisher>
			<date type="published" when="2019">2019</date>
			<biblScope unit="page" from="203" to="214" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">S-Acylation: an orchestrator of the life cycle and function of membrane proteins</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">S</forename><surname>Mesquita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Abrami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Samurkas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">G</forename><surname>Van Der Goot</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FEBS J</title>
		<imprint>
			<biblScope unit="volume">291</biblScope>
			<biblScope unit="page" from="45" to="56" />
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Dynamic palmitoylation and the role of DHHC proteins in T cell activation and anergy</title>
		<author>
			<persName><forename type="first">N</forename><surname>Ladygina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">R</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Altman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Adv. Immunol</title>
		<imprint>
			<biblScope unit="volume">109</biblScope>
			<biblScope unit="page" from="1" to="44" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Protein palmitoylation and cancer</title>
		<author>
			<persName><forename type="first">P.-J</forename><surname>Ko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Dixon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">EMBO Rep</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page">46666</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Protein palmitoylation in cancer: molecular functions and therapeutic potential</title>
		<author>
			<persName><forename type="first">B</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Hao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Liang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Oncol</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="3" to="26" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Regulation of post-translational modification of PD-L1 and advances in tumor immunotherapy</title>
		<author>
			<persName><forename type="first">C</forename><surname>Feng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Qin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Front. Immunol</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page">1230135</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Curation of the mammalian palmitoylome indicates a pivotal role for palmitoylation in diseases and disorders of the nervous system and cancers</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Sanders</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLOS Comput. Biol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">1004405</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Therapeutic targeting of protein S-acylation for the treatment of disease</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Fraser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Howie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Wypijewski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Fuller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Soc. Trans</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="281" to="290" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Lost in traffic: consequences of altered palmitoylation in neurodegeneration</title>
		<author>
			<persName><forename type="first">F</forename><surname>Ramzan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Abrar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Mishra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M Q</forename><surname>Liao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D O</forename><surname>Martin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Front. Physiol</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page">1166125</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Molecular basis of fatty acid selectivity in the zDHHC family of S-acyltransferases revealed by click chemistry</title>
		<author>
			<persName><forename type="first">J</forename><surname>Greaves</surname></persName>
		</author>
		<idno>1365-E1374</idno>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl Acad. Sci. USA</title>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Erf2, a novel gene product that affects the localization and palmitoylation of Ras2 in Saccharomyces cerevisiae</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Bartels</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Mitchell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Dong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Deschenes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Cell Biol</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="6775" to="6787" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Identification of a Ras palmitoyltransferase in Saccharomyces cerevisiae</title>
		<author>
			<persName><forename type="first">S</forename><surname>Lobo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Greentree</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Linder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Deschenes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">277</biblScope>
			<biblScope unit="page" from="41268" to="41273" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">The yeast DHHC cysteine-rich domain protein Akr1p is a palmitoyl transferase</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Roth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Feng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">G</forename><surname>Davis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Cell Biol</title>
		<imprint>
			<biblScope unit="volume">159</biblScope>
			<biblScope unit="page" from="23" to="28" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">The vacuolar DHHC-CRD protein Pfa3p is a protein acyltransferase for Vac8p</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Smotrys</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Schoenfish</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Stutz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Linder</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Cell Biol</title>
		<imprint>
			<biblScope unit="volume">170</biblScope>
			<biblScope unit="page" from="1091" to="1099" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Global profiling of dynamic protein palmitoylation</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">R</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Adibekian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Tully</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">F</forename><surname>Cravatt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Methods</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="84" to="89" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Identification of PSD-95 palmitoylating enzymes</title>
		<author>
			<persName><forename type="first">M</forename><surname>Fukata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Fukata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Adesnik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Nicoll</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Bredt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuron</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="987" to="996" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Transmembrane topology of the protein palmitoyl transferase Akr1</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">G</forename><surname>Politis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Roth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">G</forename><surname>Davis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">280</biblScope>
			<biblScope unit="page" from="10156" to="10163" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">This work presents the first structure of a ZDHHC enzyme, which reveals that the acyl chain length is defined by a long hydrophobic pocket and suggests that specific drugs could target different ZDHHCs</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Rana</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">359</biblScope>
			<biblScope unit="page">6326</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note>Fatty acyl recognition and transfer by an integral membrane S-acyltransferase</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Structure and mechanism of DHHC protein acyltransferases</title>
		<author>
			<persName><forename type="first">R</forename><surname>Stix</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C.-J</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Faraldo-Gómez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Banerjee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Mol. Biol</title>
		<imprint>
			<biblScope unit="volume">432</biblScope>
			<biblScope unit="page" from="4983" to="4998" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Structure and function of DHHC protein S-acyltransferases</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Gottlieb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Linder</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Soc. Trans</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="923" to="928" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">The cysteine-rich domain of the DHHC3 palmitoyltransferase is palmitoylated and contains tightly bound zinc</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Gottlieb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Linder</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">290</biblScope>
			<biblScope unit="page" from="29259" to="29269" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">A novel motif at the C-terminus of palmitoyltransferases is essential for Swf1 and Pfa3 function in vivo</title>
		<author>
			<persName><forename type="first">A</forename><surname>González Montoro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Quiroga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J F</forename><surname>Maccioni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Valdez Taubas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. J</title>
		<imprint>
			<biblScope unit="volume">419</biblScope>
			<biblScope unit="page" from="301" to="308" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<monogr>
		<title level="m" type="main">Identification of a novel sequence motif recognized by the ankyrin repeat domain of</title>
		<author>
			<persName><forename type="first">K</forename><surname>Lemonidis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Sanchez-Perez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Chamberlain</surname></persName>
		</author>
		<idno>zDHHC17/13</idno>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">S-Acyltransferases</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">290</biblScope>
			<biblScope unit="page" from="21939" to="21950" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<monogr>
		<title level="m" type="main">This work presents evidence for coordination between ZDHHCs in S-acylation cascades</title>
		<author>
			<persName><forename type="first">L</forename><surname>Abrami</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2017">2017</date>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">27826</biblScope>
		</imprint>
	</monogr>
	<note>Identification and dynamics of the human ZDHHC16-ZDHHC6 palmitoylation cascade. such that one acyltransferase controls the function of the next in the pathway</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Substrate recognition by the cell surface palmitoyl transferase DHHC5</title>
		<author>
			<persName><forename type="first">J</forename><surname>Howie</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl Acad. Sci. USA</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="page" from="17534" to="17539" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Substrate recruitment by zDHHC protein acyltransferases</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">I P</forename><surname>Malgapo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Linder</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Open. Biol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">210026</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Bivalent recognition of fatty acyl-CoA by a human integral membrane palmitoyltransferase</title>
		<author>
			<persName><forename type="first">C.-J</forename><surname>Lee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl Acad. Sci. USA</title>
		<imprint>
			<biblScope unit="volume">119</biblScope>
			<biblScope unit="page">2022050119</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">DHHC protein S-acyltransferases use similar ping-pong kinetic mechanisms but display different acyl-CoA specificities</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">C</forename><surname>Jennings</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Linder</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">287</biblScope>
			<biblScope unit="page" from="7236" to="7245" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Palmitoylated calnexin is a key component of the ribosometranslocon complex</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Lakkaraju</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">EMBO J</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="1823" to="1835" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Distinct acyl protein transferases and thioesterases control surface expression of calcium-activated potassium channels</title>
		<author>
			<persName><forename type="first">L</forename><surname>Tian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Mcclafferty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H.-G</forename><surname>Knaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Ruth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Shipston</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">287</biblScope>
			<biblScope unit="page" from="14718" to="14725" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<monogr>
		<title level="m" type="main">This compendium paper describes BrainPalmSeq, an interactive online tool that enables visualization of the expression patterns for S-acylating proteins in the central nervous system</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Wild</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2022">2022</date>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">75804</biblScope>
		</imprint>
	</monogr>
	<note>Exploring the expression patterns of palmitoylating and de-palmitoylating enzymes in the mouse brain using the curated RNA-seq database BrainPalmSeq</note>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">A human interactome in three quantitative dimensions organized by stoichiometries and abundances</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">Y</forename><surname>Hein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">163</biblScope>
			<biblScope unit="page" from="712" to="723" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">An optimized shotgun strategy for the rapid generation of comprehensive human proteomes</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Bekker-Jensen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Syst</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="587" to="599" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Endoplasmic reticulum localization of DHHC palmitoyltransferases mediated by lysine-based sorting signals</title>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">A</forename><surname>Gorleku</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A.-M</forename><surname>Barns</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Prescott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Greaves</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Chamberlain</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">286</biblScope>
			<biblScope unit="page" from="39573" to="39584" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Palmitoylated acyl protein thioesterase APT2 deforms membranes to extract substrate acyl chains</title>
		<author>
			<persName><forename type="first">L</forename><surname>Abrami</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Chem. Biol</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="438" to="447" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">The ER-associated protein ZDHHC1 is a positive regulator of DNA virus-triggered, MITA/STING-dependent innate immune signaling</title>
		<author>
			<persName><forename type="first">Q</forename><surname>Zhou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Host Microbe</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="450" to="461" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Dynamics of CLIMP-63 S-acylation control ER morphology</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Sandoz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Commun</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page">264</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Comparative membrane proteomics reveals diverse cell regulators concentrated at the nuclear envelope</title>
		<author>
			<persName><forename type="first">L.-C</forename><surname>Cheng</surname></persName>
		</author>
		<idno type="DOI">10.26508/lsa.202301998</idno>
		<ptr target="https://doi.org/10.26508/lsa.202301998" />
	</analytic>
	<monogr>
		<title level="j">Life Sci. Alliance</title>
		<imprint>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">S-Acylation controls SARS-CoV-2 membrane lipid organization and enhances infectivity</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">S</forename><surname>Mesquita</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Dev. Cell</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="2790" to="2807" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Intracellular localization and tissue-specific distribution of human and yeast DHHC cysteine-rich domain-containing proteins</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Ohno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kihara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Sano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Igarashi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochim. Biophys. Acta</title>
		<imprint>
			<biblScope unit="volume">1761</biblScope>
			<biblScope unit="page" from="474" to="483" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Human DHHC proteins: a spotlight on the hidden player of palmitoylation</title>
		<author>
			<persName><forename type="first">J</forename><surname>Korycka</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur. J. Cell Biol</title>
		<imprint>
			<biblScope unit="volume">91</biblScope>
			<biblScope unit="page" from="107" to="117" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Local and substrate-specific S-palmitoylation determines subcellular localization of Gα o</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">P</forename><surname>Solis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Commun</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page">2072</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Mobile DHHC palmitoylating enzyme mediates activity-sensitive synaptic targeting of PSD-95</title>
		<author>
			<persName><forename type="first">J</forename><surname>Noritake</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Cell Biol</title>
		<imprint>
			<biblScope unit="volume">186</biblScope>
			<biblScope unit="page" from="147" to="160" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Activity-regulated trafficking of the palmitoyl-acyl transferase DHHC5</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Brigidi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Santyr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Shimell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Jovellar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">X</forename><surname>Bamji</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Commun</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">8200</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Orthogonal enzyme-substrate design strategy for discovery of human protein palmitoyltransferase substrates</title>
		<author>
			<persName><forename type="first">R</forename><surname>Puthenveetil</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Am. Chem. Soc</title>
		<imprint>
			<biblScope unit="volume">145</biblScope>
			<biblScope unit="page" from="22287" to="22292" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">A palmitoyl transferase chemical-genetic system to map ZDHHC-specific S-acylation</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Ocasio</surname></persName>
		</author>
		<idno type="DOI">10.1038/s41587-023-02030-0</idno>
		<ptr target="https://doi.org/10.1038/s41587-023-02030-0" />
	</analytic>
	<monogr>
		<title level="j">Nat. Biotechnol</title>
		<imprint>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">S-Acylation of the hemagglutinin of influenza viruses: mass spectrometry reveals site-specific attachment of stearic acid to a transmembrane cysteine</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">V</forename><surname>Kordyukova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Serebryakova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Baratova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Veit</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Virol</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="page" from="9288" to="9292" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Competition for cysteine acylation by C16:0 and C18:0 derived lipids is a global phenomenon in the proteome</title>
		<author>
			<persName><forename type="first">H</forename><surname>Nůsková</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">299</biblScope>
			<biblScope unit="page">105088</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">The Golgi S-acylation machinery comprises zDHHC enzymes with major differences in substrate affinity and S-acylation activity</title>
		<author>
			<persName><forename type="first">K</forename><surname>Lemonidis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">A</forename><surname>Gorleku</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Sanchez-Perez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Grefen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Chamberlain</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Biol. Cell</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="3870" to="3883" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">S-Palmitoylation sorts membrane cargo for anterograde transport in the Golgi</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Ernst</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Dev. Cell</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="479" to="493" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note>Review article</note>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">A STAT3 palmitoylation cycle promotes T H 17 differentiation and colitis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">586</biblScope>
			<biblScope unit="page" from="434" to="439" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Structural basis for substrate recognition by the ankyrin repeat domain of human DHHC17 palmitoyltransferase</title>
		<author>
			<persName><forename type="first">R</forename><surname>Verardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J.-S</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ghirlando</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Banerjee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Structure</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="1337" to="1347" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">Peptide array-based screening reveals a large number of proteins interacting with the ankyrin-repeat domain of the zDHHC17 S-acyltransferase</title>
		<author>
			<persName><forename type="first">K</forename><surname>Lemonidis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Macleod</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Baillie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Chamberlain</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">292</biblScope>
			<biblScope unit="page" from="17190" to="17202" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">DHHC5 interacts with PDZ domain 3 of post-synaptic density-95 (PSD-95) protein and plays a role in learning and memory</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">285</biblScope>
			<biblScope unit="page" from="13022" to="13031" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">The endoplasmic reticulumlocalized enzyme zDHHC6 mediates S-acylation of short transmembrane constructs from multiple type I and II membrane proteins</title>
		<author>
			<persName><forename type="first">C</forename><surname>Salaun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">C O</forename><surname>Tomkinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Chamberlain</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">299</biblScope>
			<biblScope unit="page">105201</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Astrocyte elevated gene-1 Cys75 S-palmitoylation by ZDHHC6 regulates its biological activity</title>
		<author>
			<persName><forename type="first">G</forename><surname>Komaniecki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochemistry</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="543" to="553" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">Accessory proteins of the zDHHC family of S-acylation enzymes</title>
		<author>
			<persName><forename type="first">C</forename><surname>Salaun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Locatelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Zmuda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cabrera González</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Chamberlain</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Cell Sci</title>
		<imprint>
			<biblScope unit="volume">133</biblScope>
			<biblScope unit="page">251819</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">GCP16 stabilizes the DHHC9 subfamily of protein acyltransferases through a conserved C-terminal cysteine motif</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Nguyen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Greentree</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kawate</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Linder</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Front. Physiol</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page">1167094</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">DHHC9 and GCP16 constitute a human protein fatty acyltransferase with specificity for H-and N-Ras</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Swarthout</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">280</biblScope>
			<biblScope unit="page" from="31141" to="31148" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main">Regulation of RAS palmitoyltransferases by accessory proteins and palmitoylation</title>
		<author>
			<persName><forename type="first">A</forename><surname>Yang</surname></persName>
		</author>
		<idno type="DOI">10.1038/s41594-023-01183-5</idno>
		<ptr target="https://doi.org/10.1038/s41594-023-01183-5" />
	</analytic>
	<monogr>
		<title level="j">Nat. Struct. Biol</title>
		<imprint>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title level="a" type="main">A ZDHHC5-GOLGA7 protein acyltransferase complex promotes nonapoptotic cell death</title>
		<author>
			<persName><forename type="first">P.-J</forename><surname>Ko</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Chem. Biol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page">9</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main">S-Acylated Golga7b stabilises DHHC5 at the plasma membrane to regulate cell adhesion</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">T</forename><surname>Woodley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">O</forename><surname>Collins</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">EMBO Rep</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page">47472</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main">Control of protein palmitoylation by regulating substrate recruitment to a zDHHC-protein acyltransferase</title>
		<author>
			<persName><forename type="first">F</forename><surname>Plain</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Commun. Biol</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">411</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main">Regulatory effects of post-translational modifications on zDHHC S-acyltransferases</title>
		<author>
			<persName><forename type="first">F</forename><surname>Zmuda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Chamberlain</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">295</biblScope>
			<biblScope unit="page" from="14640" to="14652" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b78">
	<analytic>
		<title level="a" type="main">Regulation and function of the palmitoyl-acyltransferase ZDHHC5</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">T</forename><surname>Woodley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">O</forename><surname>Collins</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FEBS J</title>
		<imprint>
			<biblScope unit="volume">288</biblScope>
			<biblScope unit="page" from="6623" to="6634" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b79">
	<analytic>
		<title level="a" type="main">This work presents initial evidence for therapeutic applications of targeting protein S-acylation</title>
		<author>
			<persName><forename type="first">S</forename><surname>Chen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">549</biblScope>
			<biblScope unit="page" from="399" to="403" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note>Palmitoylation-dependent activation of MC1R prevents melanomagenesis. and deacylation</note>
</biblStruct>

<biblStruct xml:id="b80">
	<analytic>
		<title level="a" type="main">Activity-dependent post-translational regulation of palmitoylating and depalmitoylating enzymes in the hippocampus</title>
		<author>
			<persName><forename type="first">D</forename><surname>Abazari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Wild</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Qiu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">C</forename><surname>Dickinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">X</forename><surname>Bamji</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Cell Sci</title>
		<imprint>
			<biblScope unit="volume">136</biblScope>
			<biblScope unit="page">260629</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b81">
	<analytic>
		<title level="a" type="main">Targeting MC1R depalmitoylation to prevent melanomagenesis in redheads</title>
		<author>
			<persName><forename type="first">S</forename><surname>Chen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Commun</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">877</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b82">
	<analytic>
		<title level="a" type="main">Proteome scale characterization of human S-acylated proteins in lipid raft-enriched and non-raft membranes</title>
		<author>
			<persName><forename type="first">W</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Di Vizio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kirchner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Steen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Freeman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Cell Proteom</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="54" to="70" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b83">
	<analytic>
		<title level="a" type="main">Global, site-specific analysis of neuronal protein S-acylation</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">O</forename><surname>Collins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">T</forename><surname>Woodley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Choudhary</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sci. Rep</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">4683</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b84">
	<analytic>
		<title level="a" type="main">S-Acylation of SARS-CoV-2 spike protein: mechanistic dissection, in vitro reconstitution and role in viral infectivity</title>
		<author>
			<persName><forename type="first">R</forename><surname>Puthenveetil</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">297</biblScope>
			<biblScope unit="page">101112</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b85">
	<analytic>
		<title level="a" type="main">SARS-CoV-2 hijacks a cell damage response, which induces transcription of a more efficient spike S-acyltransferase</title>
		<author>
			<persName><forename type="first">S</forename><surname>Mesquita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Commun</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page">7302</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
	<note>This work presents first evidence for transcriptional regulation of different ZDHHC enzyme isoforms</note>
</biblStruct>

<biblStruct xml:id="b86">
	<analytic>
		<title level="a" type="main">Inhibitors of DHHC family proteins</title>
		<author>
			<persName><forename type="first">T</forename><surname>Lan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Delalande</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">C</forename><surname>Dickinson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr. Opin. Chem. Biol</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="118" to="125" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b87">
	<analytic>
		<title level="a" type="main">Inhibition of protein palmitoylation, raft localization, and T cell signaling by 2-bromopalmitate and polyunsaturated fatty acids</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Webb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Hermida-Matsumoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Resh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">275</biblScope>
			<biblScope unit="page" from="261" to="270" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b88">
	<analytic>
		<title level="a" type="main">Profiling targets of the irreversible palmitoylation inhibitor 2-bromopalmitate</title>
		<author>
			<persName><forename type="first">D</forename><surname>Davda</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">ACS Chem. Biol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="1912" to="1917" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b89">
	<analytic>
		<title level="a" type="main">2-Bromopalmitate reduces protein deacylation by inhibition of acyl-protein thioesterase enzymatic activities</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Pedro</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">75232</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b90">
	<analytic>
		<title level="a" type="main">Charting the chemical space of acrylamide-based inhibitors of zDHHC20</title>
		<author>
			<persName><forename type="first">S.-A</forename><surname>Azizi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Delalande</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Lan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Qiu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">C</forename><surname>Dickinson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">ACS Med. Chem. Lett</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="1648" to="1654" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b91">
	<analytic>
		<title level="a" type="main">Development of an acrylamide-based inhibitor of protein S-acylation</title>
		<author>
			<persName><forename type="first">S.-A</forename><surname>Azizi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">ACS Chem. Biol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="1546" to="1556" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b92">
	<analytic>
		<title level="a" type="main">Regulation of ERK2 activity by dynamic S-acylation</title>
		<author>
			<persName><forename type="first">S.-A</forename><surname>Azizi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Qiu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">E</forename><surname>Brookes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">C</forename><surname>Dickinson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Rep</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page">113135</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b93">
	<analytic>
		<title level="a" type="main">A high-throughput fluorescent turn-on assay for inhibitors of DHHC family proteins</title>
		<author>
			<persName><forename type="first">T</forename><surname>Qiu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S.-A</forename><surname>Azizi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Brookes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Lan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">C</forename><surname>Dickinson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">ACS Chem. Biol</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="2018" to="2023" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b94">
	<analytic>
		<title level="a" type="main">Development of a novel high-throughput screen for the identification of new inhibitors of protein S-acylation</title>
		<author>
			<persName><forename type="first">C</forename><surname>Salaun</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">298</biblScope>
			<biblScope unit="page">102469</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b95">
	<analytic>
		<title level="a" type="main">Protein depalmitoylases</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Won</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C S</forename><surname>Kit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">R</forename><surname>Martin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit. Rev. Biochem. Mol. Biol</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="83" to="98" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b96">
	<analytic>
		<title level="a" type="main">Targeting the Ras palmitoylation/depalmitoylation cycle in cancer</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">T S</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">G</forename><surname>Davis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Conibear</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Soc. Trans</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="913" to="921" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b97">
	<analytic>
		<title level="a" type="main">The crystal structure of palmitoyl protein thioesterase 1 and the molecular basis of infantile neuronal ceroid lipofuscinosis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Bellizzi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl Acad. Sci. USA</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="4573" to="4578" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b98">
	<analytic>
		<title level="a" type="main">This work presents the molecular understanding of the selectivity of two specific inhibitors of deacylation</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Won</surname></persName>
		</author>
		<idno>ML348 and ML349</idno>
	</analytic>
	<monogr>
		<title level="j">ACS Chem. Biol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="3374" to="3382" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note>Molecular mechanism for isoform-selective inhibition of acyl protein thioesterases 1 and 2 (APT1 and APT2)</note>
</biblStruct>

<biblStruct xml:id="b99">
	<analytic>
		<title level="a" type="main">Crystal structure of the human acyl protein thioesterase I from a single X-ray data set to 1.5 Å</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Devedjiev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Dauter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Kuznetsov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">L Z</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">S</forename><surname>Derewenda</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Structure</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="1137" to="1146" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b100">
	<analytic>
		<title level="a" type="main">ABHD10 is an S-depalmitoylase affecting redox homeostasis through peroxiredoxin-5</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Cao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Chem. Biol</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="1232" to="1240" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b101">
	<analytic>
		<title level="a" type="main">ABHD17 proteins are novel protein depalmitoylases that regulate N-Ras palmitate turnover and subcellular localization</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">T S</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Conibear</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">This work identifies ABHD17 proteins as deacylation enzymes</title>
		<imprint>
			<date type="published" when="2015">2015</date>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">11306</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b102">
	<analytic>
		<title level="a" type="main">Identification of PSD-95 depalmitoylating enzymes</title>
		<author>
			<persName><forename type="first">N</forename><surname>Yokoi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neurosci</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="6431" to="6444" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b103">
	<analytic>
		<title level="a" type="main">ABHD17 regulation of plasma membrane palmitoylation and N-Ras-dependent cancer growth</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Remsberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Chem. Biol</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="856" to="864" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b104">
	<analytic>
		<title level="a" type="main">Lysophospholipases cooperate to mediate lipid homeostasis and lysophospholipid signaling</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Wepy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Lipid Res</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="360" to="374" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b105">
	<analytic>
		<title level="a" type="main">In vivo metabolite profiling as a means to identify uncharacterized lipase function: recent success stories within the α/β hydrolase domain (ABHD) enzyme family</title>
		<author>
			<persName><forename type="first">G</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Brown</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochim. Biophys. Acta</title>
		<imprint>
			<biblScope unit="volume">1841</biblScope>
			<biblScope unit="page" from="1097" to="1101" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b106">
	<analytic>
		<title level="a" type="main">Discovery of triterpenoids as reversible inhibitors of α/β-hydrolase domain containing 12 (ABHD12)</title>
		<author>
			<persName><forename type="first">T</forename><surname>Parkkari</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">98286</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b107">
	<analytic>
		<title level="a" type="main">Large-scale profiling of protein palmitoylation in mammalian cells</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">R</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">F</forename><surname>Cravatt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Methods</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="135" to="138" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b108">
	<analytic>
		<title level="a" type="main">Sequence analysis and structure prediction of ABHD16A and the roles of the ABHD family members in human disease</title>
		<author>
			<persName><forename type="first">J</forename><surname>Xu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Open. Biol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">180017</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b109">
	<analytic>
		<title level="a" type="main">Active and dynamic mitochondrial S-depalmitoylation revealed by targeted fluorescent probes</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Kathayat</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Commun</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">334</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note>This work presents evidence for the mitochondrial localization and activity of APT1</note>
</biblStruct>

<biblStruct xml:id="b110">
	<analytic>
		<title level="a" type="main">Depalmitoylation by palmitoyl-protein thioesterase 1 in neuronal health and degeneration</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>Koster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Yoshii</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Front. Synaptic Neurosci</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">25</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b111">
	<analytic>
		<title level="a" type="main">Hepatic palmitoyl-proteomes and acyl-protein thioesterase protein proximity networks link lipid modification and mitochondria</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Speck</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Rep</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page">113389</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b112">
	<analytic>
		<title level="a" type="main">The autodepalmitoylating activity of APT maintains the spatial organization of palmitoylated membrane proteins</title>
		<author>
			<persName><forename type="first">N</forename><surname>Vartak</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biophys. J</title>
		<imprint>
			<biblScope unit="volume">106</biblScope>
			<biblScope unit="page" from="93" to="105" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b113">
	<analytic>
		<title level="a" type="main">Dynamic palmitoylation links cytosol-membrane shuttling of acyl-protein thioesterase-1 and acyl-protein thioesterase-2 with that of proto-oncogene H-Ras product and growth-associated protein-43</title>
		<author>
			<persName><forename type="first">E</forename><surname>Kong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">288</biblScope>
			<biblScope unit="page" from="9112" to="9125" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b114">
	<monogr>
		<title level="m" type="main">Wnt5a signaling induced phosphorylation increases APT1 activity and promotes melanoma metastatic behavior</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Sadeghi</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2018">2018</date>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">34362</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b115">
	<analytic>
		<title level="a" type="main">Synthetic fluorogenic peptides reveal dynamic substrate specificity of depalmitoylases</title>
		<author>
			<persName><forename type="first">N</forename><surname>Amara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">T</forename><surname>Foe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Onguka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Garland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bogyo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Chem. Biol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="35" to="47" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b116">
	<analytic>
		<title level="a" type="main">CellPalmSeq: a curated RNAseq database of palmitoylating and de-palmitoylating enzyme expression in human cell types and laboratory cell lines</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Wild</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Front. Physiol</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page">1110550</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b117">
	<analytic>
		<title level="a" type="main">Dynamic palmitoylation controls the microdomain localization of the DKK1 receptors CKAP4 and LRP6</title>
		<author>
			<persName><forename type="first">R</forename><surname>Sada</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sci. Signal</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">9519</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b118">
	<analytic>
		<title level="a" type="main">Small-molecule inhibition of APT1 affects Ras localization and signaling</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Dekker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Chem. Biol</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="449" to="456" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b119">
	<analytic>
		<title level="a" type="main">Characterization of a selective, reversible inhibitor of lysophospholipase 1 (LYPLA1)</title>
		<author>
			<persName><forename type="first">A</forename><surname>Adibekian</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Probe Reports from the NIH Molecular Libraries Program</title>
		<imprint>
			<publisher>NCBI</publisher>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b120">
	<analytic>
		<title level="a" type="main">Characterization of a selective, reversible inhibitor of lysophospholipase 2 (LYPLA2)</title>
		<author>
			<persName><forename type="first">A</forename><surname>Adibekian</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Probe Reports from the NIH Molecular Libraries Program</title>
		<imprint>
			<publisher>NCBI</publisher>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b121">
	<analytic>
		<title level="a" type="main">A fluorescent probe for cysteine depalmitoylation reveals dynamic APT signaling</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Kathayat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">D</forename><surname>Elvira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">C</forename><surname>Dickinson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Chem. Biol</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="150" to="152" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b122">
	<analytic>
		<title level="a" type="main">Palmitoylation couples insulin hypersecretion with β cell failure in diabetes</title>
		<author>
			<persName><forename type="first">G</forename><surname>Dong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Metab</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="332" to="344" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b123">
	<analytic>
		<title level="a" type="main">Endothelial palmitoylation cycling coordinates vessel remodeling in peripheral artery disease</title>
		<author>
			<persName><forename type="first">X</forename><surname>Wei</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ. Res</title>
		<imprint>
			<biblScope unit="volume">127</biblScope>
			<biblScope unit="page" from="249" to="265" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b124">
	<analytic>
		<title level="a" type="main">Palmitoylation is required for TNF-R1 signaling</title>
		<author>
			<persName><forename type="first">P</forename><surname>Zingler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Commun. Signal</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page">90</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b125">
	<analytic>
		<title level="a" type="main">Michael addition-based probes for ratiometric fluorescence imaging of protein S-depalmitoylases in live cells and tissues</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Beck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Kathayat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Cham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">B</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">C</forename><surname>Dickinson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chem. Sci</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="7588" to="7592" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b126">
	<analytic>
		<title level="a" type="main">Activity-based sensing of S-depalmitoylases: chemical technologies and biological discovery</title>
		<author>
			<persName><forename type="first">S.-A</forename><surname>Azizi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Kathayat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">C</forename><surname>Dickinson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acc. Chem. Res</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="3029" to="3038" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b127">
	<analytic>
		<title level="a" type="main">Palmitoylation: policing protein stability and traffic</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Linder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Deschenes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Rev. Mol. Cell Biol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="74" to="84" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b128">
	<analytic>
		<title level="a" type="main">N-Terminally myristoylated Ras proteins require palmitoylation or a polybasic domain for plasma membrane localization</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Cadwallader</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Paterson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Macdonald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Hancock</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Cell Biol</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="4722" to="4730" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b129">
	<analytic>
		<title level="a" type="main">Palmitoylation regulates raft affinity for the majority of integral raft proteins</title>
		<author>
			<persName><forename type="first">I</forename><surname>Levental</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Lingwood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Grzybek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ü</forename><surname>Coskun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Simons</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl Acad. Sci. USA</title>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="page" from="22050" to="22054" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b130">
	<analytic>
		<title level="a" type="main">Regulation of membrane protein structure and function by their lipid nano-environment</title>
		<author>
			<persName><forename type="first">I</forename><surname>Levental</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Lyman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Rev. Mol. Cell Biol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="107" to="122" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b131">
	<analytic>
		<title level="a" type="main">Structural determinants and functional consequences of protein affinity for membrane rafts</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Lorent</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Commun</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">1219</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b132">
	<analytic>
		<title level="a" type="main">Palmitoylation of voltage-gated ion channels</title>
		<author>
			<persName><forename type="first">S</forename><surname>Cassinelli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int. J. Mol. Sci</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page">9357</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b133">
	<analytic>
		<title level="a" type="main">Cardiac sodium channel palmitoylation regulates channel availability and myocyte excitability with implications for arrhythmia generation</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Pei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Xiao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Meng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hudmon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">R</forename><surname>Cummins</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Commun</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">12035</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b134">
	<analytic>
		<title level="a" type="main">Palmitoylation influences the function and pharmacology of sodium channels</title>
		<author>
			<persName><forename type="first">F</forename><surname>Bosmans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Milescu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Swartz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl Acad. Sci. USA</title>
		<imprint>
			<biblScope unit="volume">108</biblScope>
			<biblScope unit="page" from="20213" to="20218" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b135">
	<analytic>
		<title level="a" type="main">Palmitoylation of the pore-forming subunit of Ca V 1.2 controls channel voltage sensitivity and calcium transients in cardiac myocytes</title>
		<author>
			<persName><forename type="first">C.-W</forename><forename type="middle">S</forename><surname>Kuo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl Acad. Sci. USA</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="page">2207887120</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b136">
	<analytic>
		<title level="a" type="main">Palmitoylation-dependent protein sorting</title>
		<author>
			<persName><forename type="first">J</forename><surname>Greaves</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Chamberlain</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Cell Biol</title>
		<imprint>
			<biblScope unit="volume">176</biblScope>
			<biblScope unit="page" from="249" to="254" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b137">
	<analytic>
		<title level="a" type="main">Palmitoylation and ubiquitination regulate exit of the Wnt signaling protein LRP6 from the endoplasmic reticulum</title>
		<author>
			<persName><forename type="first">L</forename><surname>Abrami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Kunz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Iacovache</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">G</forename><surname>Van Der Goot</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl Acad. Sci. USA</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="page" from="5384" to="5389" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b138">
	<monogr>
		<title level="m" type="main">Ubiquitin-dependent folding of the Wnt signaling coreceptor LRP6</title>
		<author>
			<persName><forename type="first">E</forename><surname>Perrody</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2016">2016</date>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">19083</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b139">
	<analytic>
		<title level="a" type="main">ARF6 plays a general role in targeting palmitoylated proteins from the Golgi to the plasma membrane</title>
		<author>
			<persName><forename type="first">J</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Cell Sci</title>
		<imprint>
			<biblScope unit="volume">136</biblScope>
			<biblScope unit="page">261319</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b140">
	<analytic>
		<title level="a" type="main">Palmitoylation of CD36/FAT regulates the rate of its post-transcriptional processing in the endoplasmic reticulum</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">F</forename><surname>Thorne</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochim. Biophys. Acta</title>
		<imprint>
			<biblScope unit="volume">1803</biblScope>
			<biblScope unit="page" from="1298" to="1307" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b141">
	<analytic>
		<title level="a" type="main">How palmitoylation affects trafficking and signaling of membrane receptors</title>
		<author>
			<persName><forename type="first">M</forename><surname>Jansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Beaumelle</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biol. Cell</title>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<biblScope unit="page" from="61" to="72" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b142">
	<analytic>
		<title level="a" type="main">Palmitoylation-dependent control of degradation, life span, and membrane expression of the CCR5 receptor</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Percherancier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">276</biblScope>
			<biblScope unit="page" from="31936" to="31944" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b143">
	<analytic>
		<title level="a" type="main">Receptor palmitoylation and ubiquitination regulate anthrax toxin endocytosis</title>
		<author>
			<persName><forename type="first">L</forename><surname>Abrami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Leppla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">G</forename><surname>Van Der Goot</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Cell Biol</title>
		<imprint>
			<biblScope unit="volume">172</biblScope>
			<biblScope unit="page" from="309" to="320" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b144">
	<analytic>
		<title level="a" type="main">Palmitoylation regulates glutamate receptor distributions in postsynaptic densities through control of PSD95 conformation and orientation</title>
		<author>
			<persName><forename type="first">O</forename><surname>Jeyifous</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl Acad. Sci. USA</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="page">8491</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b145">
	<analytic>
		<title level="a" type="main">Palmitoylation-dependent estrogen receptor α membrane localization: regulation by 17β-estradiol</title>
		<author>
			<persName><forename type="first">F</forename><surname>Acconcia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Biol. Cell</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="231" to="237" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b146">
	<analytic>
		<title level="a" type="main">The fat controller: roles of palmitoylation in intracellular protein trafficking and targeting to membrane microdomains [Review]</title>
		<author>
			<persName><forename type="first">J</forename><surname>Greaves</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Prescott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">A</forename><surname>Gorleku</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Chamberlain</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Membr. Biol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="67" to="79" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b147">
	<analytic>
		<title level="a" type="main">Lipid and lipidation in membrane fusion</title>
		<author>
			<persName><forename type="first">A</forename><surname>Sardar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Dewangan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Panda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bhowmick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">K</forename><surname>Tarafdar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Membr. Biol</title>
		<imprint>
			<biblScope unit="volume">255</biblScope>
			<biblScope unit="page" from="691" to="703" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b148">
	<analytic>
		<title level="a" type="main">The role of S-acylation in protein trafficking</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Daniotti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Pedro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Valdez Taubas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Traffic</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="699" to="710" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b149">
	<analytic>
		<title level="a" type="main">Insulin-induced palmitoylation regulates the Cardiac Na + /Ca 2+ exchanger NCX1</title>
		<author>
			<persName><forename type="first">C</forename><surname>Gök</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Robertson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Fuller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Calcium</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="page">102567</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b150">
	<analytic>
		<title level="a" type="main">Regulation of EGFR signalling by palmitoylation and its role in tumorigenesis</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">A</forename><surname>Kadry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J.-Y</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Witze</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Open. Biol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">210033</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b151">
	<analytic>
		<title level="a" type="main">Protein modification: palmitoylation in G-protein signaling pathways</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Ross</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr. Biol</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="107" to="109" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b152">
	<analytic>
		<title level="a" type="main">DHHC5 mediates β-adrenergic signaling in cardiomyocytes by targeting Gα proteins</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">N</forename><surname>Marsden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Scott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Akimzhanov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Boehning</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biophys. J</title>
		<imprint>
			<biblScope unit="volume">118</biblScope>
			<biblScope unit="page" from="826" to="835" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b153">
	<analytic>
		<title level="a" type="main">T cell receptor-dependent S-acylation of ZAP-70 controls activation of T cells</title>
		<author>
			<persName><forename type="first">R</forename><surname>Tewari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Shayahati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Fan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Akimzhanov</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">296</biblScope>
			<biblScope unit="page">100311</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b154">
	<analytic>
		<title level="a" type="main">Dynamic S-acylation of the ER-resident protein stromal interaction molecule 1 (STIM1) is required for store-operated Ca 2+ entry</title>
		<author>
			<persName><forename type="first">G</forename><surname>Kodakandla</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">298</biblScope>
			<biblScope unit="page">102303</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b155">
	<monogr>
		<title level="m" type="main">S-Acylation by ZDHHC20 targets ORAI1 channels to lipid rafts for efficient Ca 2+ signaling by Jurkat T cell receptors at the immune synapse</title>
		<author>
			<persName><forename type="first">A</forename><surname>Carreras-Sureda</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2021">2021</date>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">72051</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b156">
	<analytic>
		<title level="a" type="main">S-Acylation of Orai1 regulates store-operated Ca 2+ entry</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>West</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Cell Sci</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="page">258579</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b157">
	<analytic>
		<title level="a" type="main">Stress-induced changes in the S-palmitoylation and S-nitrosylation of synaptic proteins</title>
		<author>
			<persName><forename type="first">M</forename><surname>Zareba-Koziol</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Cell Proteom</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<date type="published" when="1916">1916-1938 (2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b158">
	<analytic>
		<title level="a" type="main">Redox metabolism: ROS as specific molecular regulators of cell signaling and function</title>
		<author>
			<persName><forename type="first">C</forename><surname>Lennicke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Cochemé</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Cell</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="page" from="3691" to="3707" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b159">
	<analytic>
		<title level="a" type="main">Succination inactivates gasdermin D and blocks pyroptosis</title>
		<author>
			<persName><forename type="first">F</forename><surname>Humphries</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">369</biblScope>
			<biblScope unit="page" from="1633" to="1637" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b160">
	<analytic>
		<title level="a" type="main">Emerging role of PD-L1 modification in cancer immunotherapy</title>
		<author>
			<persName><forename type="first">X</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Zhou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Cancer Res</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="3832" to="3840" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b161">
	<analytic>
		<title level="a" type="main">Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies</title>
		<author>
			<persName><forename type="first">X</forename><surname>Wu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sig Transduct. Target. Ther</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">220</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b162">
	<analytic>
		<title level="a" type="main">Palmitoylation at Cys595 is essential for PECAM-1 localisation into membrane microdomains and for efficient PECAM-1-mediated cytoprotection</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">T</forename><surname>Sardjono</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Thromb. Haemost</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="page" from="756" to="766" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b163">
	<analytic>
		<title level="a" type="main">S-Palmitoylation of junctional adhesion molecule C regulates its tight junction localization and cell migration</title>
		<author>
			<persName><forename type="first">P</forename><surname>Aramsangtienchai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Spiegelman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Lin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">292</biblScope>
			<biblScope unit="page" from="5325" to="5334" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b164">
	<analytic>
		<title level="a" type="main">Palmitoylation by DHHC3 is critical for the function, expression, and stability of integrin α 6 β 4</title>
		<author>
			<persName><forename type="first">C</forename><surname>Sharma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Rabinovitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Hemler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell. Mol. Life Sci</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="2233" to="2244" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b165">
	<analytic>
		<title level="a" type="main">The extracellular domain of angulin-1 and palmitoylation of its cytoplasmic region are required for angulin-1 assembly at tricellular contacts</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Oda</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">295</biblScope>
			<biblScope unit="page" from="4289" to="4302" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b166">
	<analytic>
		<title level="a" type="main">Palmitoylation of claudins is required for efficient tight-junction localization</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Van Itallie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Gambling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Carson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Anderson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Cell Scie</title>
		<imprint>
			<biblScope unit="volume">118</biblScope>
			<biblScope unit="page" from="1427" to="1436" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b167">
	<analytic>
		<title level="a" type="main">Cell cycle-dependent palmitoylation of protocadherin 7 by ZDHHC5 promotes successful cytokinesis</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">E</forename><surname>Özkan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Cell Sci</title>
		<imprint>
			<biblScope unit="volume">136</biblScope>
			<biblScope unit="page">260266</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b168">
	<analytic>
		<title level="a" type="main">Inhibition of acetyl-CoA carboxylase impaired tubulin palmitoylation and induced spindle abnormalities</title>
		<author>
			<persName><forename type="first">C.-T</forename><surname>Fang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Death Discov</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">4</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b169">
	<analytic>
		<title level="a" type="main">Compartmentation of G protein-coupled signaling pathways in cardiac myocytes</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">F</forename><surname>Steinberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Brunton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annu. Rev. Pharmacol. Toxicol</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="751" to="773" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b170">
	<analytic>
		<title level="a" type="main">Mechanism and medical implications of mammalian autophagy</title>
		<author>
			<persName><forename type="first">I</forename><surname>Dikic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Elazar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Rev. Mol. Cell Biol</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="349" to="364" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b171">
	<analytic>
		<title level="a" type="main">A brief history of autophagy from cell biology to physiology and disease</title>
		<author>
			<persName><forename type="first">N</forename><surname>Mizushima</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Cell Biol</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="521" to="527" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b172">
	<analytic>
		<title level="a" type="main">Cellular quality control by the ubiquitin-proteasome system and autophagy</title>
		<author>
			<persName><forename type="first">C</forename><surname>Pohl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Dikic</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">366</biblScope>
			<biblScope unit="page" from="818" to="822" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b173">
	<analytic>
		<title level="a" type="main">The lipid basis of cell death and autophagy</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Lin</surname></persName>
		</author>
		<idno type="DOI">10.1080/15548627.2023.2259732</idno>
		<ptr target="https://doi.org/10.1080/15548627.2023.2259732" />
	</analytic>
	<monogr>
		<title level="j">Autophagy</title>
		<imprint>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b174">
	<analytic>
		<title level="a" type="main">Full-length huntingtin is palmitoylated at multiple sites and post-translationally myristoylated following caspase-cleavage</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">L</forename><surname>Lemarié</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Sanders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Nguyen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D O</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Hayden</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Front. Physiol</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page">1086112</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b175">
	<analytic>
		<title level="a" type="main">Akt is S-palmitoylated: a new layer of regulation for Akt</title>
		<author>
			<persName><forename type="first">M</forename><surname>Blaustein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Front. Cell Dev. Biol</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">626404</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b176">
	<analytic>
		<title level="a" type="main">mTORC1 signaling is palmitoylationdependent in hippocampal neurons and non-neuronal cells and involves dynamic palmitoylation of LAMTOR1 and mTOR</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Sanders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">I</forename><surname>De Simone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Thomas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Front. Cell Neurosci</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page">115</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b177">
	<monogr>
		<title level="m" type="main">Reduced S-acylation of SQSTM1/p62 in Huntington disease is associated with impaired autophagy</title>
		<author>
			<persName><forename type="first">F</forename><surname>Abrar</surname></persName>
		</author>
		<idno type="DOI">10.1101/2023.10.11.561600</idno>
		<ptr target="https://doi.org/10.1101/2023.10.11.561600" />
		<imprint>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
	<note type="report_type">Preprint at bioRxiv</note>
</biblStruct>

<biblStruct xml:id="b178">
	<analytic>
		<title level="a" type="main">S-Acylation of p62 promotes p62 droplet recruitment into autophagosomes in mammalian autophagy</title>
		<author>
			<persName><forename type="first">X</forename><surname>Huang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Cell</title>
		<imprint>
			<biblScope unit="volume">83</biblScope>
			<biblScope unit="page">11</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b179">
	<analytic>
		<title level="a" type="main">Regulatory effects of protein S-acylation on insulin secretion and insulin action</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Chamberlain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Shipston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Gould</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Open. Biol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">210017</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b180">
	<analytic>
		<title level="a" type="main">Nutrient-induced metabolic stress, adaptation, detoxification, and toxicity in the pancreatic β-cell</title>
		<author>
			<persName><forename type="first">M</forename><surname>Prentki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M.-L</forename><surname>Peyot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Masiello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R M</forename><surname>Madiraju</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="279" to="290" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b181">
	<analytic>
		<title level="a" type="main">Post-translational palmitoylation of metabolic proteins</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M J H</forename><surname>Dennis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Heather</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Front. Physiol</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page">1122895</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b182">
	<analytic>
		<title level="a" type="main">Dynamic role of the transmembrane glycoprotein CD36 (SR-B2) in cellular fatty acid uptake and utilization</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Glatz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F P</forename><surname>Luiken</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Lipid Res</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="1084" to="1093" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b183">
	<analytic>
		<title level="a" type="main">DHHC4 and DHHC5 facilitate fatty acid uptake by palmitoylating and targeting CD36 to the plasma membrane</title>
		<author>
			<persName><forename type="first">J</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Rep</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="209" to="221" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b184">
	<analytic>
		<title level="a" type="main">KLF10 promotes nonalcoholic steatohepatitis progression through transcriptional activation of zDHHC7</title>
		<author>
			<persName><forename type="first">S</forename><surname>Yang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">EMBO Rep</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page">54229</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b185">
	<analytic>
		<title level="a" type="main">Selenoprotein K is required for palmitoylation of CD36 in macrophages: implications in foam cell formation and atherogenesis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Meiler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Leukoc. Biol</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="page" from="771" to="780" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b186">
	<analytic>
		<title level="a" type="main">Oxidized high-density lipoprotein promotes CD36 palmitoylation and increases lipid uptake in macrophages</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">298</biblScope>
			<biblScope unit="page">102000</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b187">
	<analytic>
		<title level="a" type="main">Insulin-induced translocation of CD36 to the plasma membrane is reversible and shows similarity to that of GLUT4</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Van Oort</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochim. Biophys. Acta</title>
		<imprint>
			<biblScope unit="volume">1781</biblScope>
			<biblScope unit="page" from="61" to="71" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b188">
	<analytic>
		<title level="a" type="main">CD36 facilitates fatty acid uptake by dynamic palmitoylation-regulated endocytosis</title>
		<author>
			<persName><forename type="first">J.-W</forename><surname>Hao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Commun</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">4765</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b189">
	<analytic>
		<title level="a" type="main">Glut4 palmitoylation at Cys223 plays a critical role in Glut4 membrane trafficking</title>
		<author>
			<persName><forename type="first">W</forename><surname>Ren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Du</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Biophys. Res. Commun</title>
		<imprint>
			<biblScope unit="volume">460</biblScope>
			<biblScope unit="page" from="709" to="714" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b190">
	<analytic>
		<title level="a" type="main">DHHC7 palmitoylates glucose transporter 4 (Glut4) and regulates Glut4 membrane translocation</title>
		<author>
			<persName><forename type="first">K</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Murakami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Kilpatrick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Luscher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">292</biblScope>
			<biblScope unit="page" from="2979" to="2991" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b191">
	<analytic>
		<title level="a" type="main">DHHC17 palmitoylates ClipR-59 and modulates ClipR-59 association with the plasma membrane</title>
		<author>
			<persName><forename type="first">W</forename><surname>Ren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Du</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Cell Biol</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="4255" to="4265" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b192">
	<analytic>
		<title level="a" type="main">Metformin alleviates inflammation through suppressing FASN-dependent palmitoylation of Akt</title>
		<author>
			<persName><forename type="first">W</forename><surname>Xiong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Death Dis</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">934</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b193">
	<analytic>
		<title level="a" type="main">DHHC17 is a new regulator of AMPK signaling</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Du</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Cell Biol</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page">13122</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b194">
	<analytic>
		<title level="a" type="main">Protein S-palmitoylation in immunity</title>
		<author>
			<persName><forename type="first">T</forename><surname>Das</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Yount</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Hang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Open. Biol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">200411</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b195">
	<analytic>
		<title level="a" type="main">Toll-like receptor mediated inflammation requires FASN-dependent MYD88 palmitoylation</title>
		<author>
			<persName><forename type="first">Y.-C</forename><surname>Kim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Chem. Biol</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="907" to="916" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b196">
	<analytic>
		<title level="a" type="main">Transmembrane TNF (pro-TNF) is palmitoylated</title>
		<author>
			<persName><forename type="first">T</forename><surname>Utsumi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FEBS Lett</title>
		<imprint>
			<biblScope unit="volume">500</biblScope>
			<biblScope unit="page" from="1" to="6" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b197">
	<analytic>
		<title level="a" type="main">Targeting LYPLAL1-mediated cGAS depalmitoylation enhances the response to anti-tumor immunotherapy</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Fan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Cell</title>
		<imprint>
			<biblScope unit="volume">83</biblScope>
			<biblScope unit="page" from="3520" to="3532" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b198">
	<analytic>
		<title level="a" type="main">ZDHHC18 negatively regulates cGAS-mediated innate immunity through palmitoylation</title>
		<author>
			<persName><forename type="first">C</forename><surname>Shi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">EMBO J</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page">109272</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b199">
	<analytic>
		<title level="a" type="main">Activation of STING requires palmitoylation at the Golgi</title>
		<author>
			<persName><forename type="first">K</forename><surname>Mukai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Commun</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">11932</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b200">
	<analytic>
		<title level="a" type="main">This work identifies compounds that specifically target S-acylated Cys</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Haag</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">559</biblScope>
			<biblScope unit="page" from="269" to="273" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note>Targeting STING with covalent small-molecule inhibitors. in STING as selective inhibitors of targeted S-acylation</note>
</biblStruct>

<biblStruct xml:id="b201">
	<analytic>
		<title level="a" type="main">Cell biology of inflammasome activation</title>
		<author>
			<persName><forename type="first">A</forename><surname>Pandey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Feng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Man</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Trends Cell Biol</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="924" to="939" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b202">
	<analytic>
		<title level="a" type="main">Palmitoylation prevents sustained inflammation by limiting NLRP3 inflammasome activation through chaperone-mediated autophagy</title>
		<author>
			<persName><forename type="first">L</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Cell</title>
		<imprint>
			<biblScope unit="volume">83</biblScope>
			<biblScope unit="page">10</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b203">
	<analytic>
		<title level="a" type="main">The NLRP3 inflammasome: molecular activation and regulation to therapeutics</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">V</forename><surname>Swanson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Deng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Ting</surname></persName>
		</author>
		<author>
			<persName><forename type="first">-Y</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Rev. Immunol</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="477" to="489" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b204">
	<analytic>
		<title level="a" type="main">ZDHHC5-mediated NLRP3 palmitoylation promotes NLRP3-NEK7 interaction and inflammasome activation</title>
		<author>
			<persName><forename type="first">S</forename><surname>Zheng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Cell</title>
		<imprint>
			<biblScope unit="volume">83</biblScope>
			<biblScope unit="page" from="4570" to="4585" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b205">
	<analytic>
		<title level="a" type="main">Palmitoylation of NOD1 and NOD2 is required for bacterial sensing</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Lu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">366</biblScope>
			<biblScope unit="page" from="460" to="467" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b206">
	<analytic>
		<title level="a" type="main">Palmitoylation facilitates inflammation through suppressing NOD2 degradation mediated by the selective autophagy receptor SQSTM1</title>
		<author>
			<persName><forename type="first">L</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zeng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Autophagy</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="2254" to="2255" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b207">
	<analytic>
		<title level="a" type="main">Molecular mechanisms of gasdermin D pore-forming activity</title>
		<author>
			<persName><forename type="first">P</forename><surname>Devant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Kagan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Immunol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="1064" to="1075" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b208">
	<analytic>
		<title level="a" type="main">Chemical disruption of the pyroptotic pore-forming protein gasdermin D inhibits inflammatory cell death and sepsis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Rathkey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sci. Immunol</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">2738</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b209">
	<analytic>
		<title level="a" type="main">FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Hu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Immunol</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="736" to="745" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b210">
	<analytic>
		<title level="a" type="main">Gasdermin D pore-forming activity is redox-sensitive</title>
		<author>
			<persName><forename type="first">P</forename><surname>Devant</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Rep</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page">112008</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b211">
	<analytic>
		<title level="a" type="main">Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores</title>
		<author>
			<persName><forename type="first">X</forename><surname>Liu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">535</biblScope>
			<biblScope unit="page" from="153" to="158" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b212">
	<monogr>
		<title level="m" type="main">Palmitoylation of gasdermin D directs its membrane translocation and pore formation in pyroptosis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Balasubramanian</surname></persName>
		</author>
		<idno type="DOI">10.1101/2023.02.21.529402</idno>
		<ptr target="https://doi.org/10.1101/2023.02.21.529402" />
		<imprint>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
	<note type="report_type">Preprint at bioRxiv</note>
</biblStruct>

<biblStruct xml:id="b213">
	<monogr>
		<title level="m" type="main">ROS-dependent palmitoylation is an obligate licensing modification for GSDMD pore formation</title>
		<author>
			<persName><forename type="first">G</forename><surname>Du</surname></persName>
		</author>
		<idno type="DOI">10.1101/2023.03.07.531538</idno>
		<ptr target="https://doi.org/10.1101/2023.03.07.531538" />
		<imprint>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
	<note type="report_type">Preprint at bioRxiv</note>
</biblStruct>

<biblStruct xml:id="b214">
	<analytic>
		<title level="a" type="main">Inhibition of gasdermin D palmitoylation by disulfiram is crucial for the treatment of myocardial infarction</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Zhuang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Yang</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.trsl.2023.09.007</idno>
		<ptr target="https://doi.org/10.1016/j.trsl.2023.09.007" />
	</analytic>
	<monogr>
		<title level="j">Transl. Res</title>
		<imprint>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b215">
	<analytic>
		<title level="a" type="main">DHHC5 protein palmitoylates flotillin-2 and is rapidly degraded on induction of neuronal differentiation in cultured cells</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">R</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">F</forename><surname>Cravatt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Hofmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">287</biblScope>
			<biblScope unit="page" from="523" to="530" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b216">
	<analytic>
		<title level="a" type="main">S-Palmitoylation during retinoic acid-induced neuronal differentiation of SH-SY5Y neuroblastoma cells</title>
		<author>
			<persName><forename type="first">S</forename><surname>Sardana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Nederstigt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Baggelaar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Proteome Res</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="2421" to="2435" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b217">
	<monogr>
		<title level="m" type="main">The X-linked intellectual disability gene, ZDHHC9, is important for oligodendrocyte maturation and myelin formation</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Hollman</surname></persName>
		</author>
		<idno type="DOI">10.1101/2023.08.08.552342</idno>
		<imprint>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
	<note type="report_type">Preprint at bioRxiv https</note>
</biblStruct>

<biblStruct xml:id="b218">
	<analytic>
		<title level="a" type="main">The X-linked intellectual disability gene Zdhhc9 is essential for dendrite outgrowth and inhibitory synapse formation</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Shimell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Rep</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="2422" to="2437" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b219">
	<analytic>
		<title level="a" type="main">Regulation of dendrite morphology and excitatory synapse formation by zDHHC15</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Shah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Shimell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">X</forename><surname>Bamji</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Cell Sci</title>
		<imprint>
			<biblScope unit="volume">132</biblScope>
			<biblScope unit="page">230052</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b220">
	<analytic>
		<title level="a" type="main">Palmitoylation-dependent neurodevelopmental deficits in a mouse model of 22q11 microdeletion</title>
		<author>
			<persName><forename type="first">J</forename><surname>Mukai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Neurosci</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="1302" to="1310" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b221">
	<analytic>
		<title level="a" type="main">Protein palmitoylation in the development and plasticity of neuronal connections</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Globa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">X</forename><surname>Bamji</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr. Opin. Neurobiol</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="210" to="220" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b222">
	<analytic>
		<title level="a" type="main">Palmitoylation of δ-catenin by DHHC5 mediates activity-induced synapse plasticity</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Brigidi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Neurosci</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="522" to="532" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b223">
	<analytic>
		<title level="a" type="main">CaMKII regulates the depalmitoylation and synaptic removal of the scaffold protein AKAP79/150 to mediate structural long-term depression</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Woolfrey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">293</biblScope>
			<biblScope unit="page" from="1551" to="1567" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b224">
	<analytic>
		<title level="a" type="main">The palmitoyl acyltransferase DHHC2 regulates recycling endosome exocytosis and synaptic potentiation through palmitoylation of AKAP79/150</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Woolfrey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Sanderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Dell'acqua</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neurosci</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="442" to="456" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b225">
	<analytic>
		<title level="a" type="main">Palmitoylation of gephyrin controls receptor clustering and plasticity of GABAergic synapses</title>
		<author>
			<persName><forename type="first">B</forename><surname>Dejanovic</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS Biol</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">1001908</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b226">
	<analytic>
		<title level="a" type="main">Protein palmitoylation in neuronal development and synaptic plasticity</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Fukata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fukata</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Rev. Neurosci</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="161" to="175" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b227">
	<analytic>
		<title level="a" type="main">Palmitoylated Sept8-204 modulates learning and anxiety by regulating filopodia arborization and actin dynamics</title>
		<author>
			<persName><forename type="first">H</forename><surname>Liu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sci. Signal</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page">8645</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b228">
	<analytic>
		<title level="a" type="main">Synaptic activity-dependent changes in the hippocampal palmitoylome</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Nasseri</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sci. Signal</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page">2519</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b229">
	<analytic>
		<title level="a" type="main">DHHC2 regulates fear memory formation, LTP, and AKAP150 signaling in the hippocampus</title>
		<author>
			<persName><forename type="first">M.-D</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">iScience</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page">107561</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b230">
	<analytic>
		<title level="a" type="main">Deficiency of the palmitoyl acyltransferase ZDHHC7 impacts brain and behavior of mice in a sex-specific manner</title>
		<author>
			<persName><forename type="first">C</forename><surname>Hohoff</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain Struct. Funct</title>
		<imprint>
			<biblScope unit="volume">224</biblScope>
			<biblScope unit="page" from="2213" to="2230" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note>ZDHHC. on brain anatomy, microstructure, connectivity, function and behaviour</note>
</biblStruct>

<biblStruct xml:id="b231">
	<monogr>
		<title level="m" type="main">A sticky situation: regulation and function of protein palmitoylation with a spotlight on the axon and axon initial segment</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Petropavlovskiy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Kogut</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Leekha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Townsend</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Sanders</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note>Neuronal Signal. 5, NS20210005</note>
</biblStruct>

<biblStruct xml:id="b232">
	<analytic>
		<title level="a" type="main">S-palmitoylation of synaptic proteins in neuronal plasticity in normal and pathological brains</title>
		<author>
			<persName><forename type="first">A</forename><surname>Buszka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pytyś</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Colvin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Włodarczyk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Wójtowicz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cells</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">387</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b233">
	<analytic>
		<title level="a" type="main">DHHC5 facilitates oligodendrocyte development by palmitoylating and activating STAT3</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Ma</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Glia</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="page" from="379" to="392" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b234">
	<analytic>
		<title level="a" type="main">Palmitoylation is a sorting determinant for transport to the myelin membrane</title>
		<author>
			<persName><forename type="first">A</forename><surname>Schneider</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Cell Sci</title>
		<imprint>
			<biblScope unit="volume">118</biblScope>
			<biblScope unit="page" from="2415" to="2423" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b235">
	<analytic>
		<title level="a" type="main">A toxic palmitoylation of Cdc42 enhances NF-κB signaling and drives a severe autoinflammatory syndrome</title>
		<author>
			<persName><forename type="first">B</forename><surname>Bekhouche</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Allergy Clin. Immunol</title>
		<imprint>
			<biblScope unit="volume">146</biblScope>
			<biblScope unit="page" from="1201" to="1204" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b236">
	<monogr>
		<title level="m" type="main">Palmitoyl transferase ZDHHC20 promotes pancreatic cancer metastasis</title>
		<author>
			<persName><forename type="first">G</forename><surname>Tomić</surname></persName>
		</author>
		<idno type="DOI">10.1101/2023.02.08.527637</idno>
		<ptr target="https://doi.org/10.1101/2023.02.08.527637" />
		<imprint>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
	<note type="report_type">Preprint at bioRxiv</note>
</biblStruct>

<biblStruct xml:id="b237">
	<analytic>
		<title level="a" type="main">Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours</title>
		<author>
			<persName><forename type="first">H</forename><surname>Yao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Biomed. Eng</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="306" to="317" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b238">
	<analytic>
		<title level="a" type="main">Palmitoylation stabilizes PD-L1 to promote breast tumor growth</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Yang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Res</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="83" to="86" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b239">
	<analytic>
		<title level="a" type="main">Targeting ZDHHC9 potentiates anti-programmed death-ligand 1 immunotherapy of pancreatic cancer by modifying the tumor microenvironment</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Lin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biomed. Pharmacother</title>
		<imprint>
			<biblScope unit="volume">161</biblScope>
			<biblScope unit="page">114567</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b240">
	<analytic>
		<title level="a" type="main">Pyroptosis provides new strategies for the treatment of cancer</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Jia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Cancer</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="140" to="151" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b241">
	<analytic>
		<title level="a" type="main">Chemotherapy-induced pyroptosis is mediated by BAK/BAX-caspase-3-GSDME pathway and inhibited by 2-bromopalmitate</title>
		<author>
			<persName><forename type="first">L</forename><surname>Hu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Death Dis</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">281</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b242">
	<analytic>
		<title level="a" type="main">Causes and consequences of micronuclei</title>
		<author>
			<persName><forename type="first">K</forename><surname>Krupina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Goginashvili</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Cleveland</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr. Opin. Cell Biol</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="page" from="91" to="99" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b243">
	<analytic>
		<title level="a" type="main">Recurrent loss of STING signaling in melanoma correlates with susceptibility to viral oncolysis</title>
		<author>
			<persName><forename type="first">T</forename><surname>Xia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Konno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">N</forename><surname>Barber</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">76</biblScope>
			<biblScope unit="page" from="6747" to="6759" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b244">
	<analytic>
		<title level="a" type="main">Decreased expression of STING predicts poor prognosis in patients with gastric cancer</title>
		<author>
			<persName><forename type="first">S</forename><surname>Song</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sci. Rep</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">39858</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b245">
	<analytic>
		<title level="a" type="main">DHHC9-mediated GLUT1 S-palmitoylation promotes glioblastoma glycolysis and tumorigenesis</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Commun</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">5872</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b246">
	<analytic>
		<title level="a" type="main">Rescue of aberrant huntingtin palmitoylation ameliorates mutant huntingtin-induced toxicity</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">L</forename><surname>Lemarié</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurobiol. Dise</title>
		<imprint>
			<biblScope unit="volume">158</biblScope>
			<biblScope unit="page">105479</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b247">
	<analytic>
		<title level="a" type="main">Increasing brain palmitoylation rescues behavior and neuropathology in Huntington disease mice</title>
		<author>
			<persName><forename type="first">A</forename><surname>Virlogeux</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sci. Adv</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">799</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b248">
	<analytic>
		<title level="a" type="main">Altered regulation of striatal neuronal N-methyl-d-aspartate receptor trafficking by palmitoylation in Huntington disease mouse model</title>
		<author>
			<persName><forename type="first">R</forename><surname>Kang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Front. Synaptic Neurosci</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">3</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b249">
	<analytic>
		<title level="a" type="main">Aberrant palmitoylation in Huntington disease</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Sanders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Hayden</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Soc. Trans</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="205" to="210" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b250">
	<analytic>
		<title level="a" type="main">Palmitoylation of the Parkinson&apos;s disease-associated protein synaptotagmin-11 links its turnover to α-synuclein homeostasis</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">P H</forename><surname>Ho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Wilkie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>White</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Selkoe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sci. Signal</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page">7220</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b251">
	<monogr>
		<title level="m" type="main">Unconventional secretion of α-synuclein mediated by palmitoylated DNAJC5 oligomers</title>
		<author>
			<persName><forename type="first">S</forename><surname>Wu</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2023">2023</date>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">85837</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b252">
	<analytic>
		<title level="a" type="main">Palmitoylated APP forms dimers, cleaved by BACE1</title>
		<author>
			<persName><forename type="first">R</forename><surname>Bhattacharyya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Fenn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Barren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Tanzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Kovacs</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">166400</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b253">
	<analytic>
		<title level="a" type="main">Palmitoylation of amyloid precursor protein regulates amyloidogenic processing in lipid rafts</title>
		<author>
			<persName><forename type="first">R</forename><surname>Bhattacharyya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Barren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Kovacs</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neurosci</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="11169" to="11183" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b254">
	<analytic>
		<title level="a" type="main">Altered cortical palmitoylation induces widespread molecular disturbances in Parkinson&apos;s disease</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Cervilla-Martínez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int. J. Mol. Sci</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page">14018</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b255">
	<analytic>
		<title level="a" type="main">Aberrant palmitoylation caused by a ZDHHC21 mutation contributes to pathophysiology of Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">W</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Med</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page">223</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b256">
	<analytic>
		<title level="a" type="main">ZDHHC9 X-linked intellectual disability: clinical and molecular characterization</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K S</forename><surname>Ramos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Med. Genet. Pt A</title>
		<imprint>
			<biblScope unit="volume">191</biblScope>
			<biblScope unit="page" from="599" to="604" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b257">
	<analytic>
		<title level="a" type="main">Mutation in ZDHHC15 leads to hypotonic cerebral palsy, autism, epilepsy, and intellectual disability</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Lewis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurol. Genet</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">602</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b258">
	<analytic>
		<title level="a" type="main">ZDHHC15 as a candidate gene for autism spectrum disorder</title>
		<author>
			<persName><forename type="first">D</forename><surname>Casellas-Vidal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Med. Genet. Pt A</title>
		<imprint>
			<biblScope unit="volume">191</biblScope>
			<biblScope unit="page" from="941" to="947" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b259">
	<analytic>
		<title level="a" type="main">Integrating genome-wide association study and expression quantitative trait locus study identifies multiple genes and gene sets associated with schizophrenia</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Progr Neuropsychopharmacol. Biol. Psychiatry</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="page" from="50" to="54" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b260">
	<analytic>
		<title level="a" type="main">Evidence that the gene encoding ZDHHC8 contributes to the risk of schizophrenia</title>
		<author>
			<persName><forename type="first">J</forename><surname>Mukai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="725" to="731" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b261">
	<analytic>
		<title level="a" type="main">Local palmitoylation cycles define activity-regulated postsynaptic subdomains</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Fukata</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Cell Biol</title>
		<imprint>
			<biblScope unit="volume">202</biblScope>
			<biblScope unit="page" from="145" to="161" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b262">
	<analytic>
		<title level="a" type="main">2-Bromopalmitate and 2-(2-hydroxy-5-nitro-benzylidene)-benzo[b] thiophen-3-one inhibit DHHC-mediated palmitoylation in vitro</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">C</forename><surname>Jennings</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Lipid Res</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="page" from="233" to="242" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>Review article</note>
</biblStruct>

<biblStruct xml:id="b263">
	<analytic>
		<title level="a" type="main">/β-Hydrolase domain (ABHD) inhibitors as new potential therapeutic options against lipid-related diseases</title>
		<author>
			<persName><forename type="first">G</forename><surname>Bononi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Tuccinardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Rizzolio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Granchi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Med. Chem</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="9759" to="9785" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b264">
	<analytic>
		<title level="a" type="main">CSS-Palm: palmitoylation site prediction with a clustering and scoring strategy (CSS)</title>
		<author>
			<persName><forename type="first">F</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Xue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Yao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Xu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="894" to="896" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b265">
	<analytic>
		<title level="a" type="main">PalmPred: an SVM based palmitoylation prediction method using sequence profile information</title>
		<author>
			<persName><forename type="first">B</forename><surname>Kumari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kumar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">89246</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b266">
	<analytic>
		<title level="a" type="main">Global analysis of endogenously intact S-acylated peptides reveals localization differentiation of heterogeneous lipid chains in mammalian cells</title>
		<author>
			<persName><forename type="first">G</forename><surname>Ji</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Anal. Chem</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="13055" to="13063" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b267">
	<analytic>
		<title level="a" type="main">Proteome-scale analysis of protein S-acylation comes of age</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Yang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Proteome Res</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="14" to="26" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
